{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:29:50Z","timestamp":1793852990653,"version":"4.6.1"},"reference-count":549,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-024-01889-x","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:03:01Z","timestamp":1730368981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":206,"title":["Hallmarks\u00a0of primary headache: part 1 \u2013 migraine"],"prefix":"10.1186","volume":"25","author":[{"given":"Alberto","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Caponnetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Della Pietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garcia-Azorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Gazerani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou","family":"Grangeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Grazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Jung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Labastida-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Sophie","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Lisicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Marcassoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Antonio","family":"Montisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Onan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Onofri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfranco","family":"Pellesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Petru\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Rubio-Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Straube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Straube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Vigneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doga","family":"Vuralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Waliszewska-Pros\u00f3\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wells-Gatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tissa","family":"Wijeratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"1889_CR1","first-page":"344","volume":"23","author":"GBD","year":"2021","unstructured":"GBD (2021) Nervous System Disorders Collaborators (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23:344\u2013381","journal-title":"Lancet Neurol"},{"key":"1889_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M et al (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23:34","journal-title":"J Headache Pain"},{"key":"1889_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0140-6736(18)30478-1","volume":"391","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) Migraine. Lancet 391:1315\u20131330","journal-title":"Lancet"},{"key":"1889_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10194-021-01281-z","volume":"22","author":"V Caponnetto","year":"2021","unstructured":"Caponnetto V, Deodato M, Robotti M et al (2021) Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain 22:71","journal-title":"J Headache Pain"},{"key":"1889_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life. J Headache Pain 20:41","journal-title":"J Headache Pain"},{"key":"1889_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10194-024-01735-0","volume":"25","author":"M Waliszewska-Pros\u00f3\u0142","year":"2024","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Montisano DA, Antolak M et al (2024) The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study. J Headache Pain 25:27","journal-title":"J Headache Pain"},{"key":"1889_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s10194-023-01666-2","volume":"24","author":"P Martelletti","year":"2023","unstructured":"Martelletti P, Leonardi M, Ashina M et al (2023) Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030. J Headache Pain 24:140","journal-title":"J Headache Pain"},{"key":"1889_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10194-023-01554-9","volume":"24","author":"TJ Steiner","year":"2023","unstructured":"Steiner TJ, Hus\u00f8y A, Thomas H et al (2023) The HARDSHIP databases: a forthcoming free good from the Global Campaign against Headache. J Headache Pain 24:21","journal-title":"J Headache Pain"},{"key":"1889_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/ene.14098","volume":"27","author":"M Viana","year":"2020","unstructured":"Viana M, Khaliq F, Zecca C et al (2020) Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort. Eur J Neurol 27:536\u2013541","journal-title":"Eur J Neurol"},{"key":"1889_CR10","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s00415-021-10715-2","volume":"269","author":"E Caronna","year":"2022","unstructured":"Caronna E, Gallardo VJ, Alpuente A et al (2022) Epidemiology, work and economic impact of migraine in a large hospital cohort: time to raise awareness and promote sustainability. J Neurol 269:1456\u20131462","journal-title":"J Neurol"},{"key":"1889_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s10194-023-01700-3","volume":"25","author":"M Leonardi","year":"2024","unstructured":"Leonardi M, Martelletti P, Burstein R et al (2024) The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders. J Headache Pain 25:4","journal-title":"J Headache Pain"},{"key":"1889_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-021-01305-8","volume":"22","author":"M Tinelli","year":"2021","unstructured":"Tinelli M, Leonardi M, Paemeleire K et al (2021) Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions. J Headache Pain 22:90","journal-title":"J Headache Pain"},{"key":"1889_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","volume":"20","author":"TJ Steiner","year":"2019","unstructured":"Steiner TJ, Jensen R, Katsarava Z et al (2019) Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain 20:57","journal-title":"J Headache Pain"},{"key":"1889_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s10194-023-01623-z","volume":"24","author":"J Pascual","year":"2023","unstructured":"Pascual J, Panni T, Dell\u2019Agnello G et al (2023) Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study. J Headache Pain 24:88","journal-title":"J Headache Pain"},{"key":"1889_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","volume":"24","author":"C Lampl","year":"2023","unstructured":"Lampl C, MaassenVanDenBrink A, Deligianni CI et al (2023) The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. J Headache Pain 24:56","journal-title":"J Headache Pain"},{"key":"1889_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s10194-022-01401-3","volume":"23","author":"YC Cheng","year":"2022","unstructured":"Cheng YC, Zeng BY, Hung CM et al (2022) Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials. J Headache Pain 23:28","journal-title":"J Headache Pain"},{"key":"1889_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/medicina58010044","volume":"58","author":"JY Bae","year":"2021","unstructured":"Bae JY, Sung HK, Kwon NY et al (2021) Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas) 58:44","journal-title":"Medicina (Kaunas)"},{"key":"1889_CR18","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1212\/WNL.43.7.1369","volume":"43","author":"MB Russell","year":"1993","unstructured":"Russell MB, Hilden J, S\u00f8rensen SA et al (1993) Olesen J. Familial occurrence of migraine without aura and migraine with aura. Neurology 43:1369\u20131373","journal-title":"Neurology"},{"key":"1889_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/bmj.311.7004.541","volume":"311","author":"MB Russell","year":"1995","unstructured":"Russell MB, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. BMJ 311:541\u2013544","journal-title":"BMJ"},{"key":"1889_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","volume":"87","author":"RA Ophoff","year":"1996","unstructured":"Ophoff RA, Terwindt GM, Vergouwe MN et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543\u2013552","journal-title":"Cell"},{"key":"1889_CR21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ana.10674","volume":"54","author":"KR Vanmolkot","year":"2003","unstructured":"Vanmolkot KR, Kors EE, Hottenga JJ et al (2003) Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 54:360\u2013366","journal-title":"Ann Neurol"},{"key":"1889_CR22","doi-asserted-by":"publisher","first-page":"e142202","DOI":"10.1172\/JCI142202","volume":"131","author":"E Auffenberg","year":"2021","unstructured":"Auffenberg E, Hedrich UB, Barbieri R et al (2021) Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model. J Clin Invest 131:e142202","journal-title":"J Clin Invest"},{"key":"1889_CR23","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1212\/WNL.0000000000012947","volume":"98","author":"F Riant","year":"2022","unstructured":"Riant F, Roos C, Roubertie A et al (2022) Hemiplegic migraine associated with PRRT2 variations: a clinical and genetic study. Neurology 98:e51\u2013e61","journal-title":"Neurology"},{"key":"1889_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/STROKEAHA.109.568402","volume":"41","author":"P Adib-Samii","year":"2010","unstructured":"Adib-Samii P, Brice G, Martin RJ, Markus HS et al (2010) Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 41:630\u2013634","journal-title":"Stroke"},{"key":"1889_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41588-021-00990-0","volume":"54","author":"H Hautakangas","year":"2022","unstructured":"Hautakangas H, Winsvold BS, Ruotsalainen SE et al (2022) Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet 54:152\u2013160","journal-title":"Nat Genet"},{"key":"1889_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/03331024211045651","volume":"42","author":"P H\u00e4pp\u00f6l\u00e4","year":"2022","unstructured":"H\u00e4pp\u00f6l\u00e4 P, Gormley P, Nuottamo ME et al (2022) Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families. Cephalalgia 42:345\u2013356","journal-title":"Cephalalgia"},{"key":"1889_CR27","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41431-018-0150-2","volume":"26","author":"Y Yang","year":"2018","unstructured":"Yang Y, Zhao H, Boomsma DI et al (2018) Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet 26:1202\u20131216","journal-title":"Eur J Hum Genet"},{"key":"1889_CR28","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1038\/s41467-020-17002-0","volume":"11","author":"Y Guo","year":"2020","unstructured":"Guo Y, Rist PM, Daghlas I et al (2020) A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine. Nat Commun 11:3368","journal-title":"Nat Commun"},{"key":"1889_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrneurol.2013.192","volume":"9","author":"AC Charles","year":"2013","unstructured":"Charles AC, Baca SM (2013) Cortical spreading depression and migraine. Nat Rev Neurol 9:637\u2013644","journal-title":"Nat Rev Neurol"},{"key":"1889_CR30","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1177\/0333102418761041","volume":"38","author":"ME Hiekkala","year":"2018","unstructured":"Hiekkala ME, Vuola P, Artto V et al (2018) The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: a clinical and genetic study in Finnish migraine families. Cephalalgia 38:1849\u20131863","journal-title":"Cephalalgia"},{"key":"1889_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1474-4422(11)70048-5","volume":"10","author":"MB Russell","year":"2011","unstructured":"Russell MB, Ducros A (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10:457\u2013470","journal-title":"Lancet Neurol"},{"key":"1889_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1468-2982.2002.00371.x","volume":"22","author":"L Lykke Thomsen","year":"2002","unstructured":"Lykke Thomsen L, Kirchmann Eriksen M, Faerch Romer S et al (2002) An epidemiological survey of hemiplegic migraine. Cephalalgia 22:361\u2013375","journal-title":"Cephalalgia"},{"key":"1889_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211","journal-title":"Cephalalgia"},{"key":"1889_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1468-1331.2003.00621.x","volume":"10","author":"LL Thomsen","year":"2003","unstructured":"Thomsen LL, Olesen J, Russell MB (2003) Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur J Neurol 10:421\u2013427","journal-title":"Eur J Neurol"},{"key":"1889_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fphys.2016.00239","volume":"7","author":"T Friedrich","year":"2016","unstructured":"Friedrich T, Tavraz NN, Junghans C (2016) ATP1A2 Mutations in Migraine: Seeing through the Facets of an Ion Pump onto the Neurobiology of Disease. Front Physiol 7:239","journal-title":"Front Physiol"},{"key":"1889_CR36","first-page":"100140","volume":"3","author":"S Guey","year":"2022","unstructured":"Guey S, Herv\u00e9 D (2022) Main features of COL4A1-COL4A2 related cerebral microangiopathies. Cereb Circ Cogn Behav 3:100140","journal-title":"Cereb Circ Cogn Behav"},{"key":"1889_CR37","first-page":"100046","volume":"3","author":"AE Wilms","year":"2022","unstructured":"Wilms AE, de Boer I, Terwindt GM (2022) Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations (RVCL-S): An update on basic science and clinical perspectives. Cereb Circ Cogn Behav 3:100046","journal-title":"Cereb Circ Cogn Behav"},{"key":"1889_CR38","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nm.2216","volume":"16","author":"RG Lafreni\u00e8re","year":"2010","unstructured":"Lafreni\u00e8re RG, Cader MZ, Poulin JF et al (2010) A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16:1157\u20131160","journal-title":"Nat Med"},{"key":"1889_CR39","doi-asserted-by":"publisher","first-page":"183ra56, 1-11","DOI":"10.1126\/scitranslmed.3005784","volume":"5","author":"KC Brennan","year":"2013","unstructured":"Brennan KC, Bates EA, Shapiro RE et al (2013) Casein kinase i\u03b4 mutations in familial migraine and advanced sleep phase. Sci Transl Med 5:183ra56, 1\u201311","journal-title":"Sci Transl Med"},{"key":"1889_CR40","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/s41436-019-0476-3","volume":"21","author":"LB Williams","year":"2019","unstructured":"Williams LB, Javed A, Sabri A et al (2019) ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder. Genet Med 21:2103\u20132115","journal-title":"Genet Med"},{"key":"1889_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3598","volume":"48","author":"P Gormley","year":"2016","unstructured":"Gormley P, Anttila V, Winsvold BS et al (2016) Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 48:856\u2013866","journal-title":"Nat Genet"},{"key":"1889_CR42","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s42003-021-02356-y","volume":"4","author":"H Choquet","year":"2021","unstructured":"Choquet H, Yin J, Jacobson AS et al (2021) New and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis. Commun Biol 4:864","journal-title":"Commun Biol"},{"key":"1889_CR43","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.neuron.2018.04.014","volume":"98","author":"P Gormley","year":"2018","unstructured":"Gormley P, Kurki MI, Hiekkala ME et al (2018) Common variant burden contributes to the familial aggregation of migraine in 1,589 families. Neuron 98:743-753.e744","journal-title":"Neuron"},{"key":"1889_CR44","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1212\/WNL.0000000000001606","volume":"84","author":"R Malik","year":"2015","unstructured":"Malik R, Freilinger T, Winsvold BS et al (2015) Shared genetic basis for migraine and ischemic stroke: a genome-wide analysis of common variants. Neurology 84:2132\u20132145","journal-title":"Neurology"},{"key":"1889_CR45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/ene.14111","volume":"27","author":"I Daghlas","year":"2020","unstructured":"Daghlas I, Guo Y, Chasman DI (2020) Effect of genetic liability to migraine on coronary artery disease and atrial fibrillation: a Mendelian randomization study. Eur J Neurol 27:550\u2013556","journal-title":"Eur J Neurol"},{"key":"1889_CR46","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1002\/acn3.51228","volume":"7","author":"I Daghlas","year":"2020","unstructured":"Daghlas I, Vgontzas A, Guo Y et al (2020) Habitual sleep disturbances and migraine: a Mendelian randomization study. Ann Clin Transl Neurol 7:2370\u20132380","journal-title":"Ann Clin Transl Neurol"},{"key":"1889_CR47","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/genes11030268","volume":"11","author":"EO Adewuyi","year":"2020","unstructured":"Adewuyi EO, Sapkota Y, International Endogene Consortium Iec et al (2020) Shared molecular genetic mechanisms underlie endometriosis and migraine comorbidity. Genes (Basel) 11:268","journal-title":"Genes (Basel)"},{"key":"1889_CR48","doi-asserted-by":"publisher","first-page":"930383","DOI":"10.3389\/fneur.2022.930383","volume":"13","author":"K Kamm","year":"2022","unstructured":"Kamm K (2022) CGRP and migraine: what have we learned from measuring CGRP in migraine patients so far? Front Neurol 13:930383","journal-title":"Front Neurol"},{"key":"1889_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1468-2982.2003.00552.x","volume":"23","author":"V Gallai","year":"2003","unstructured":"Gallai V, Alberti A, Gallai B et al (2003) Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 23:166\u2013174","journal-title":"Cephalalgia"},{"key":"1889_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54\u201361","journal-title":"Cephalalgia"},{"key":"1889_CR51","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","volume":"14","author":"S Eftekhari","year":"2013","unstructured":"Eftekhari S, Warfvinge K, Blixt FW et al (2013) Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system. J Pain 14:1289\u20131303","journal-title":"J Pain"},{"key":"1889_CR52","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41467-022-28204-z","volume":"13","author":"F De Logu","year":"2022","unstructured":"De Logu F, Nassini R, Hegron A et al (2022) Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice. Nat Commun 13:646","journal-title":"Nat Commun"},{"key":"1889_CR53","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.tips.2023.07.003","volume":"44","author":"TA Rees","year":"2023","unstructured":"Rees TA, Labastida-Ram\u00edrez A, Rubio-Beltr\u00e1n E (2023) Calcitonin\/PAC1 receptor splice variants: a blind spot in migraine research. Trends Pharmacol Sci 44:651\u2013663","journal-title":"Trends Pharmacol Sci"},{"issue":"Suppl 2","key":"1889_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/head.13081","volume":"57","author":"L Edvinsson","year":"2017","unstructured":"Edvinsson L (2017) The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine. Headache 57(Suppl 2):47\u201355","journal-title":"Headache"},{"key":"1889_CR55","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neuropharm.2016.12.024","volume":"116","author":"E Kilinc","year":"2017","unstructured":"Kilinc E, Guerrero-Toro C, Zakharov A et al (2017) Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain. Neuropharmacology 116:160\u2013173","journal-title":"Neuropharmacology"},{"key":"1889_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s10194-023-01710-1","volume":"25","author":"A Della Pietra","year":"2024","unstructured":"Della Pietra A, G\u00f3mez Dab\u00f3 L, Mikulenka P et al (2024) Mechanosensitive receptors in migraine: a systematic review. J Headache Pain 25:6","journal-title":"J Headache Pain"},{"key":"1889_CR57","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/ana.26072","volume":"89","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Karagholi MA, Walker CS et al (2021) Amylin analog pramlintide induces migraine-like attacks in patients. Ann Neurol 89:1157\u20131171","journal-title":"Ann Neurol"},{"key":"1889_CR58","doi-asserted-by":"publisher","unstructured":"Labastida-Ram\u00edrez A, Runio-Beltran E, Holland PR, et al. (2024) Sexually dimorphic effects of Amylin 1 receptor activation in trigeminovascular neurons. bioRxiv. 2024.01.12.575235. https:\/\/doi.org\/10.1101\/2024.01.12.575235","DOI":"10.1101\/2024.01.12.575235"},{"key":"1889_CR59","doi-asserted-by":"publisher","first-page":"860037","DOI":"10.3389\/fphys.2022.860037","volume":"13","author":"TA Rees","year":"2022","unstructured":"Rees TA, Russo AF, O\u2019Carroll SJ et al (2022) CGRP and the calcitonin receptor are co-expressed in mouse, rat and human trigeminal ganglia neurons. Front Physiol 13:860037","journal-title":"Front Physiol"},{"key":"1889_CR60","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/ph16030438","volume":"16","author":"MA Al-Karagholi","year":"2023","unstructured":"Al-Karagholi MA (2023) Involvement of potassium channel signalling in migraine pathophysiology. Pharmaceuticals (Basel) 16:438","journal-title":"Pharmaceuticals (Basel)"},{"key":"1889_CR61","doi-asserted-by":"crossref","unstructured":"Fahrenkrug J, Goetzl EJ, Gozes I, et al (2023) VIP and PACAP receptors in GtoPdb v.2023.1. Available from: https:\/\/journals.ed.ac.uk\/gtopdb-cite\/article\/view\/8714. Accessed 12 July 2024","DOI":"10.2218\/gtopdb\/F67\/2023.1"},{"key":"1889_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar AJ, Fahrenkrug J, Gozes I et al (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166:4\u201317","journal-title":"Br J Pharmacol"},{"key":"1889_CR63","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T et al (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16\u201325","journal-title":"Brain"},{"key":"1889_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0333102419864507","volume":"40","author":"H Ghanizada","year":"2020","unstructured":"Ghanizada H, Al-Karagholi MA, Arngrim N et al (2020) PACAP27 induces migraine-like attacks in migraine patients. Cephalalgia 40:57\u201367","journal-title":"Cephalalgia"},{"key":"1889_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s10194-018-0893-8","volume":"19","author":"E Rubio-Beltr\u00e1n","year":"2018","unstructured":"Rubio-Beltr\u00e1n E, Correnti E, Deen M et al (2018) PACAP38 and PAC1 receptor blockade: a new target for headache? J Headache Pain 19:64","journal-title":"J Headache Pain"},{"key":"1889_CR66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/bph.15700","volume":"179","author":"Z Tasma","year":"2022","unstructured":"Tasma Z, Siow A, Harris PWR et al (2022) Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery. Br J Pharmacol 179:435\u2013453","journal-title":"Br J Pharmacol"},{"key":"1889_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-024-01796-1","volume":"25","author":"J Olesen","year":"2024","unstructured":"Olesen J (2024) Provocation of attacks to discover migraine signaling mechanisms and new drug targets: early history and future perspectives - a narrative review. J Headache Pain 25:105","journal-title":"J Headache Pain"},{"key":"1889_CR68","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1046\/j.1468-2982.1999.019007660.x","volume":"19","author":"I Christiansen","year":"1999","unstructured":"Christiansen I, Thomsen LL, Daugaard D et al (1999) Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 19:660\u2013667","journal-title":"Cephalalgia"},{"key":"1889_CR69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0140-6736(97)80021-9","volume":"349","author":"LH Lassen","year":"1997","unstructured":"Lassen LH, Ashina M, Christiansen I et al (1997) Nitric oxide synthase inhibition in migraine. Lancet 349:401\u2013402","journal-title":"Lancet"},{"key":"1889_CR70","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/01.WCB.0000143536.22131.D7","volume":"24","author":"S Birk","year":"2004","unstructured":"Birk S, Kruuse C, Petersen KA et al (2004) The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab 24:1352\u20131358","journal-title":"J Cereb Blood Flow Metab"},{"key":"1889_CR71","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1526-4610.2009.01512.x","volume":"50","author":"CJ Schankin","year":"2010","unstructured":"Schankin CJ, Kruse LS, Reinisch VM et al (2010) Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5. Headache 50:431\u2013441","journal-title":"Headache"},{"key":"1889_CR72","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/0333102413515345","volume":"34","author":"JC Nordgaard","year":"2014","unstructured":"Nordgaard JC, Kruse LS, M\u00f8ller M et al (2014) Phosphodiesterases 3 and 5 express activity in the trigeminal ganglion and co-localize with calcitonin gene-related peptide. Cephalalgia 34:503\u2013513","journal-title":"Cephalalgia"},{"key":"1889_CR73","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/brain\/awu244","volume":"137","author":"S Guo","year":"2014","unstructured":"Guo S, Olesen J, Ashina M (2014) Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain 137:2951\u20132959","journal-title":"Brain"},{"key":"1889_CR74","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/0333102420915166","volume":"40","author":"K Falkenberg","year":"2020","unstructured":"Falkenberg K, Bjerg HR, Olesen J (2020) Subcutaneous sumatriptan reduces cilostazol induced headache in migraine patients. Cephalalgia 40:842\u2013850","journal-title":"Cephalalgia"},{"key":"1889_CR75","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1177\/0333102419882474","volume":"39","author":"S Younis","year":"2019","unstructured":"Younis S, Christensen CE, Toft NM et al (2019) Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil. Cephalalgia 39:1776\u20131788","journal-title":"Cephalalgia"},{"key":"1889_CR76","doi-asserted-by":"publisher","first-page":"333102424125948","DOI":"10.1177\/03331024241259489","volume":"44","author":"B Raffaelli","year":"2024","unstructured":"Raffaelli B, Do TP, Ashina H et al (2024) Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation. Cephalalgia 44:3331024241259489","journal-title":"Cephalalgia"},{"key":"1889_CR77","doi-asserted-by":"publisher","first-page":"12268","DOI":"10.3390\/ijms241512268","volume":"24","author":"M Silvestro","year":"2023","unstructured":"Silvestro M, Iannone LF, Orologio I et al (2023) Migraine Treatment: Towards New Pharmacological Targets. Int J Mol Sci 24:12268","journal-title":"Int J Mol Sci"},{"key":"1889_CR78","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1085\/jgp.110.6.655","volume":"110","author":"S Shyng","year":"1997","unstructured":"Shyng S, Nichols CG (1997) Octameric stoichiometry of the KATP channel complex. J Gen Physiol 110:655\u2013664","journal-title":"J Gen Physiol"},{"key":"1889_CR79","doi-asserted-by":"publisher","first-page":"333102424124821","DOI":"10.1177\/03331024241248211","volume":"44","author":"L Kokoti","year":"2024","unstructured":"Kokoti L, Al-Karagholi MA, Zhuang ZA et al (2024) Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: a randomized clinical trial. Cephalalgia 44:3331024241248211","journal-title":"Cephalalgia"},{"key":"1889_CR80","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/ph16020225","volume":"16","author":"T Dyhring","year":"2023","unstructured":"Dyhring T, Jansen-Olesen I, Christophersen P et al (2023) Pharmacological profiling of KATP channel modulators: an outlook for new treatment opportunities for migraine. Pharmaceuticals (Basel) 16:225","journal-title":"Pharmaceuticals (Basel)"},{"key":"1889_CR81","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/brain\/awab136","volume":"144","author":"MA Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA, Ghanizada H, Nielsen CAW et al (2021) Opening of ATP sensitive potassium channels causes migraine attacks with aura. Brain 144:2322\u20132332","journal-title":"Brain"},{"key":"1889_CR82","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/brain\/awz199","volume":"142","author":"MA Al-Karagholi","year":"2019","unstructured":"Al-Karagholi MA, Hansen JM, Guo S et al (2019) Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain 142:2644\u20132654","journal-title":"Brain"},{"key":"1889_CR83","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1097\/j.pain.0000000000002238","volume":"162","author":"MA Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA, Ghanizada H, Waldorff Nielsen CA et al (2021) Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine. Pain 162:2512\u20132520","journal-title":"Pain"},{"key":"1889_CR84","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/j.pain.0000000000001801","volume":"161","author":"A Labastida-Ram\u00edrez","year":"2020","unstructured":"Labastida-Ram\u00edrez A, Rubio-Beltr\u00e1n E, Haanes KA et al (2020) Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system. Pain 161:1092\u20131099","journal-title":"Pain"},{"key":"1889_CR85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2010.09.004","volume":"1361","author":"JD Classey","year":"2010","unstructured":"Classey JD, Bartsch T, Goadsby PJ (2010) Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans. Brain Res 1361:76\u201385","journal-title":"Brain Res"},{"key":"1889_CR86","doi-asserted-by":"publisher","first-page":"136380","DOI":"10.1016\/j.neulet.2021.136380","volume":"768","author":"LF Iannone","year":"2022","unstructured":"Iannone LF, De Logu F, Geppetti P et al (2022) The role of TRP ion channels in migraine and headache. Neurosci Lett 768:136380","journal-title":"Neurosci Lett"},{"key":"1889_CR87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s10194-022-01525-6","volume":"23","author":"R Messina","year":"2022","unstructured":"Messina R, Cetta I, Colombo B et al (2022) Tracking the evolution of non-headache symptoms through the migraine attack. J Headache Pain 23:149","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"1889_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","volume":"58","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) A phase-by-phase review of migraine pathophysiology. Headache 58(Suppl 1):4\u201316","journal-title":"Headache"},{"key":"1889_CR89","doi-asserted-by":"publisher","first-page":"1032103","DOI":"10.3389\/fneur.2022.1032103","volume":"13","author":"M Vincent","year":"2022","unstructured":"Vincent M, Viktrup L, Nicholson RA et al (2022) The not so hidden impact of interictal burden in migraine: a narrative review. Front Neurol 13:1032103","journal-title":"Front Neurol"},{"key":"1889_CR90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.nrl.2017.09.014","volume":"36","author":"AB Gago-Veiga","year":"2021","unstructured":"Gago-Veiga AB, Vivancos J, Sobrado M (2021) The premonitory phase: A crucial stage in migraine. Neurologia (Engl Ed) 36:298\u2013304","journal-title":"Neurologia (Engl Ed)"},{"key":"1889_CR91","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s10194-022-01510-z","volume":"23","author":"AK Eigenbrodt","year":"2022","unstructured":"Eigenbrodt AK, Christensen RH, Ashina H et al (2022) Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency. J Headache Pain 23:140","journal-title":"J Headache Pain"},{"key":"1889_CR92","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10194-023-01617-x","volume":"24","author":"N Karsan","year":"2023","unstructured":"Karsan N, Goadsby PJ (2023) Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review. J Headache Pain 24:106","journal-title":"J Headache Pain"},{"key":"1889_CR93","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s10194-023-01683-1","volume":"24","author":"RB Lipton","year":"2023","unstructured":"Lipton RB, Lanteri-Minet M, Leroux E et al (2023) Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study. J Headache Pain 24:151","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"1889_CR94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10072-017-2866-0","volume":"38","author":"A May","year":"2017","unstructured":"May A (2017) Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging. Neurol Sci 38(Suppl 1):125\u2013130","journal-title":"Neurol Sci"},{"key":"1889_CR95","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/brain\/117.1.199","volume":"117","author":"M Lauritzen","year":"1994","unstructured":"Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117:199\u2013210","journal-title":"Brain"},{"key":"1889_CR96","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1073\/pnas.071582498","volume":"98","author":"N Hadjikhani","year":"2001","unstructured":"Hadjikhani N, Sanchez Del Rio M, Wu O et al (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 98:4687\u20134692","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1889_CR97","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1097\/j.pain.0000000000001676","volume":"160","author":"MJ Lee","year":"2019","unstructured":"Lee MJ, Park BY, Cho S et al (2019) Dynamic functional connectivity of the migraine brain: a resting-state functional magnetic resonance imaging study. Pain 160:2776\u20132786","journal-title":"Pain"},{"key":"1889_CR98","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1231897","volume":"339","author":"H Karatas","year":"2013","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y et al (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339:1092\u20131095","journal-title":"Science"},{"issue":"Suppl 1","key":"1889_CR99","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","volume":"154","author":"R Noseda","year":"2013","unstructured":"Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain 154(Suppl 1):S44-53","journal-title":"Pain"},{"key":"1889_CR100","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","volume":"75","author":"D Pietrobon","year":"2013","unstructured":"Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365\u2013391","journal-title":"Annu Rev Physiol"},{"key":"1889_CR101","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1177\/0333102418784698","volume":"39","author":"M Vila-Pueyo","year":"2019","unstructured":"Vila-Pueyo M, Hoffmann J, Romero-Reyes M et al (2019) Brain structure and function related to headache: Brainstem structure and function in headache. Cephalalgia 39:1635\u20131660","journal-title":"Cephalalgia"},{"key":"1889_CR102","doi-asserted-by":"publisher","first-page":"333102423120637","DOI":"10.1177\/03331024231206376","volume":"43","author":"RH Christensen","year":"2023","unstructured":"Christensen RH, Eigenbrodt AK, Ashina H et al (2023) What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies. Cephalalgia 43:3331024231206376","journal-title":"Cephalalgia"},{"key":"1889_CR103","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s10194-024-01716-3","volume":"25","author":"J Thuraiaiyah","year":"2024","unstructured":"Thuraiaiyah J, Ashina H, Christensen RH et al (2024) Postdromal symptoms in migraine: a REFORM study. J Headache Pain 25:25","journal-title":"J Headache Pain"},{"key":"1889_CR104","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clinph.2015.05.028","volume":"127","author":"F Brighina","year":"2016","unstructured":"Brighina F, Cosentino G, Fierro B (2016) Habituation or lack of habituation: What is really lacking in migraine? Clin Neurophysiol 127:19\u201320","journal-title":"Clin Neurophysiol"},{"key":"1889_CR105","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1515\/sjpain-2021-0050","volume":"21","author":"S Di Antonio","year":"2021","unstructured":"Di Antonio S, Castaldo M, Ponzano M et al (2021) Disability, burden, and symptoms related to sensitization in migraine patients associate with headache frequency. Scand J Pain 21:766\u2013777","journal-title":"Scand J Pain"},{"key":"1889_CR106","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1038\/s41598-021-82080-z","volume":"11","author":"SM Han","year":"2021","unstructured":"Han SM, Kim KM, Cho SJ et al (2021) Prevalence and characteristics of cutaneous allodynia in probable migraine. Sci Rep 11:2467","journal-title":"Sci Rep"},{"key":"1889_CR107","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00702-019-02089-7","volume":"127","author":"G Coppola","year":"2020","unstructured":"Coppola G, Parisi V, Di Renzo A et al (2020) Cortical pain processing in migraine. J Neural Transm (Vienna) 127:551\u2013566","journal-title":"J Neural Transm (Vienna)"},{"issue":"Suppl 1","key":"1889_CR108","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1007\/s10072-013-1382-0","volume":"34","author":"M Aguggia","year":"2013","unstructured":"Aguggia M, Saracco MG, Cavallini M et al (2013) Sensitization and pain. Neurol Sci 34(Suppl 1):S37-40","journal-title":"Neurol Sci"},{"key":"1889_CR109","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21994","volume":"68","author":"R Burstein","year":"2010","unstructured":"Burstein R, Jakubowski M, Garcia-Nicas E et al (2010) Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol 68:81\u201391","journal-title":"Ann Neurol"},{"key":"1889_CR110","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/WCO.0000000000001065","volume":"35","author":"D Martinelli","year":"2022","unstructured":"Martinelli D, Pocora MM, De Icco R et al (2022) Triggers of migraine: where do we stand? Curr Opin Neurol 35:360\u2013366","journal-title":"Curr Opin Neurol"},{"key":"1889_CR111","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/B978-0-12-823356-6.00014-7","volume":"198","author":"LH Fischer-Schulte","year":"2023","unstructured":"Fischer-Schulte LH (2023) Peng KP (2023) Migraine prodromes and migraine triggers. Handb Clin Neurol 198:135\u2013148","journal-title":"Handb Clin Neurol"},{"key":"1889_CR112","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10194-019-1002-3","volume":"20","author":"A Russo","year":"2019","unstructured":"Russo A, Tessitore A, Silvestro M et al (2019) Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura. J Headache Pain 20:46","journal-title":"J Headache Pain"},{"key":"1889_CR113","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/brain\/awz405","volume":"143","author":"MJ Burke","year":"2020","unstructured":"Burke MJ, Joutsa J, Cohen AL et al (2020) Mapping migraine to a common brain network. Brain 143:541\u2013553","journal-title":"Brain"},{"key":"1889_CR114","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1073\/pnas.071582498","volume":"98","author":"N Hadjikhani","year":"2001","unstructured":"Hadjikhani N, Del Rio MS, Wu O et al (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci 98:4687\u20134692","journal-title":"Proc Natl Acad Sci"},{"key":"1889_CR115","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/ene.12451","volume":"21","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Schankin C et al (2014) Photic hypersensitivity in the premonitory phase of migraine \u2013 a positron emission tomography study. Eur J Neurol 21:1178\u20131183","journal-title":"Eur J Neurol"},{"key":"1889_CR116","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3389\/fneur.2019.01325","volume":"10","author":"F Puledda","year":"2019","unstructured":"Puledda F, Ffytche D, O\u2019Daly O et al (2019) Imaging the Visual Network in the Migraine Spectrum. Front Neurol 10:1325","journal-title":"Front Neurol"},{"key":"1889_CR117","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/brain\/aww097","volume":"139","author":"LH Schulte","year":"2016","unstructured":"Schulte LH, May A (2016) The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 139:1987\u20131993","journal-title":"Brain"},{"key":"1889_CR118","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.25697","volume":"87","author":"LH Schulte","year":"2020","unstructured":"Schulte LH, Mehnert J, May A (2020) Longitudinal neuroimaging over 30 days: temporal characteristics of migraine. Ann Neurol 87:646\u2013651","journal-title":"Ann Neurol"},{"key":"1889_CR119","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1474-4422(14)70193-0","volume":"14","author":"TJ Schwedt","year":"2015","unstructured":"Schwedt TJ, Chiang C-C, Chong CD et al (2015) Functional MRI of migraine. Lancet Neurol 14:81\u201391","journal-title":"Lancet Neurol"},{"key":"1889_CR120","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/cercor\/bhq109","volume":"21","author":"EA Moulton","year":"2011","unstructured":"Moulton EA, Becerra L, Maleki N et al (2011) Painful heat reveals hyperexcitability of the temporal pole in interictal and ictal migraine States. Cereb Cortex 21:435\u2013448","journal-title":"Cereb Cortex"},{"key":"1889_CR121","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/0333102414526069","volume":"34","author":"TJ Schwedt","year":"2014","unstructured":"Schwedt TJ, Chong CD, Chiang CC et al (2014) Enhanced pain-induced activity of pain-processing regions in a case-control study of episodic migraine. Cephalalgia 34:947\u2013958","journal-title":"Cephalalgia"},{"key":"1889_CR122","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1468-2982.2009.01890.x","volume":"30","author":"JH Kim","year":"2010","unstructured":"Kim JH, Kim S, Suh S-I et al (2010) Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study. Cephalalgia 30:53\u201361","journal-title":"Cephalalgia"},{"key":"1889_CR123","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/head.12587","volume":"55","author":"A Tessitore","year":"2015","unstructured":"Tessitore A, Russo A, Conte F et al (2015) Abnormal connectivity within executive resting-state network in migraine with aura. Headache 55:794\u2013805","journal-title":"Headache"},{"key":"1889_CR124","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1177\/0333102416652091","volume":"37","author":"CD Chong","year":"2017","unstructured":"Chong CD, Gaw N, Fu Y et al (2017) Migraine classification using magnetic resonance imaging resting-state functional connectivity data. Cephalalgia 37:828\u2013844","journal-title":"Cephalalgia"},{"key":"1889_CR125","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.pain.2011.11.029","volume":"153","author":"N Szabo","year":"2012","unstructured":"Szabo N, Kincses ZT, P\u00e1rdutz \u00c1 et al (2012) White matter microstructural alterations in migraine: a diffusion-weighted MRI study. Pain 153:651\u2013656","journal-title":"Pain"},{"key":"1889_CR126","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1212\/WNL.0000000000002261","volume":"86","author":"FM Amin","year":"2016","unstructured":"Amin FM, Hougaard A, Magon S et al (2016) Change in brain network connectivity during PACAP38-induced migraine attacks: a resting-state functional MRI study. Neurology 86:180\u2013187","journal-title":"Neurology"},{"key":"1889_CR127","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.nic.2019.01.009","volume":"29","author":"BM Ellingson","year":"2019","unstructured":"Ellingson BM, Hesterman C, Johnston M et al (2019) Advanced imaging in the evaluation of migraine headaches. Neuroimaging Clin N Am 29:301\u2013324","journal-title":"Neuroimaging Clin N Am"},{"key":"1889_CR128","doi-asserted-by":"publisher","first-page":"1112790","DOI":"10.3389\/fnhum.2023.1112790","volume":"17","author":"N Karsan","year":"2023","unstructured":"Karsan N, Silva E, Goadsby PJ (2023) Evaluating migraine with typical aura with neuroimaging. Front Hum Neurosci 17:1112790","journal-title":"Front Hum Neurosci"},{"key":"1889_CR129","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/brain\/awx382","volume":"141","author":"D Gaist","year":"2018","unstructured":"Gaist D, Hougaard A, Garde E et al (2018) Migraine with visual aura associated with thicker visual cortex. Brain 141:776\u2013785","journal-title":"Brain"},{"key":"1889_CR130","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1177\/0333102414566860","volume":"35","author":"H Bridge","year":"2015","unstructured":"Bridge H, Stagg CJ, Near J et al (2015) Altered neurochemical coupling in the occipital cortex in migraine with visual aura. Cephalalgia 35:1025\u20131030","journal-title":"Cephalalgia"},{"key":"1889_CR131","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/0333102415584360","volume":"36","author":"G Tedeschi","year":"2016","unstructured":"Tedeschi G, Russo A, Conte F et al (2016) Increased interictal visual network connectivity in patients with migraine with aura. Cephalalgia 36:139\u2013147","journal-title":"Cephalalgia"},{"key":"1889_CR132","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/0333102412474503","volume":"33","author":"R Datta","year":"2013","unstructured":"Datta R, Aguirre GK, Hu S et al (2013) Interictal cortical hyperresponsiveness in migraine is directly related to the presence of aura. Cephalalgia 33:365\u2013374","journal-title":"Cephalalgia"},{"key":"1889_CR133","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3389\/fneur.2019.01039","volume":"10","author":"P Farag\u00f3","year":"2019","unstructured":"Farag\u00f3 P, T\u00f3th E, Kocsis K et al (2019) Altered resting state functional activity and microstructure of the white matter in migraine with aura. Front Neurol 10:1039","journal-title":"Front Neurol"},{"key":"1889_CR134","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/hbm.23548","volume":"38","author":"A Hougaard","year":"2017","unstructured":"Hougaard A, Amin F, Larsson H et al (2017) Increased intrinsic brain connectivity between pons and somatosensory cortex during attacks of migraine with aura. Hum Brain Mapp 38:2635\u20132642","journal-title":"Hum Brain Mapp"},{"key":"1889_CR135","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s10194-022-01446-4","volume":"23","author":"G Coppola","year":"2022","unstructured":"Coppola G, Corbelli I, Di Renzo A et al (2022) Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks. J Headache Pain 23:80","journal-title":"J Headache Pain"},{"key":"1889_CR136","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ana.410130609","volume":"13","author":"M Lauritzen","year":"1983","unstructured":"Lauritzen M, Olsen TS, Lassen NA et al (1983) Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 13:633\u2013641","journal-title":"Ann Neurol"},{"key":"1889_CR137","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s10194-022-01501-0","volume":"23","author":"T Fu","year":"2022","unstructured":"Fu T, Liu L, Huang X et al (2022) Cerebral blood flow alterations in migraine patients with and without aura: an arterial spin labeling study. J Headache Pain 23:131","journal-title":"J Headache Pain"},{"key":"1889_CR138","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s10194-022-01430-y","volume":"23","author":"RH Christensen","year":"2022","unstructured":"Christensen RH, Gollion C, Amin FM et al (2022) Imaging the inflammatory phenotype in migraine. J Headache Pain 23:60","journal-title":"J Headache Pain"},{"key":"1889_CR139","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/ene.15061","volume":"29","author":"M Silvestro","year":"2022","unstructured":"Silvestro M, Tessitore A, Di Nardo F et al (2022) Functional connectivity changes in complex migraine aura: beyond the visual network. Eur J Neurol 29:295\u2013304","journal-title":"Eur J Neurol"},{"key":"1889_CR140","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3389\/fneur.2019.01112","volume":"10","author":"I Petrusic","year":"2019","unstructured":"Petrusic I, Viana M, Dakovic M et al (2019) Application of the migraine aura complexity score (MACS): clinical and neuroimaging study. Front Neurol 10:1112","journal-title":"Front Neurol"},{"key":"1889_CR141","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s10194-021-01272-0","volume":"22","author":"G Coppola","year":"2021","unstructured":"Coppola G, Di Renzo A, Tinelli E et al (2021) Thalamo-cortical networks in subtypes of migraine with aura patients. J Headache Pain 22:58","journal-title":"J Headache Pain"},{"key":"1889_CR142","doi-asserted-by":"publisher","first-page":"1146302","DOI":"10.3389\/fnhum.2023.1146302","volume":"17","author":"C Abagnale","year":"2023","unstructured":"Abagnale C, Di Renzo A, Sebastianelli G et al (2023) Whole brain surface-based morphometry and tract-based spatial statistics in migraine with aura patients: difference between pure visual and complex auras. Front Hum Neurosci 17:1146302","journal-title":"Front Hum Neurosci"},{"key":"1889_CR143","doi-asserted-by":"publisher","first-page":"1106612","DOI":"10.3389\/fneur.2023.1106612","volume":"14","author":"K Mitrovi\u0107","year":"2023","unstructured":"Mitrovi\u0107 K, Petru\u0161i\u0107 I, Radoji\u010di\u0107 A et al (2023) Migraine with aura detection and subtype classification using machine learning algorithms and morphometric magnetic resonance imaging data. Front Neurol 14:1106612","journal-title":"Front Neurol"},{"key":"1889_CR144","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s10194-023-01704-z","volume":"24","author":"K Mitrovi\u0107","year":"2023","unstructured":"Mitrovi\u0107 K, Savi\u0107 AM, Radoji\u010di\u0107 A (2023) Machine learning approach for Migraine Aura Complexity Score prediction based on magnetic resonance imaging data. J Headache Pain 24:169","journal-title":"J Headache Pain"},{"key":"1889_CR145","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-019-0986-z","volume":"20","author":"MJ Lee","year":"2019","unstructured":"Lee MJ, Park BY, Cho S et al (2019) Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study. J Headache Pain 20:29","journal-title":"J Headache Pain"},{"key":"1889_CR146","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-017-0825-z","volume":"18","author":"G Coppola","year":"2017","unstructured":"Coppola G, Petolicchio B, Di Renzo A et al (2017) Cerebral gray matter volume in patients with chronic migraine: correlations with clinical features. J Headache Pain 18:115","journal-title":"J Headache Pain"},{"key":"1889_CR147","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1177\/0333102416630593","volume":"36","author":"TH Lai","year":"2016","unstructured":"Lai TH, Chou KH, Fuh JL et al (2016) Gray matter changes related to medication overuse in patients with chronic migraine. Cephalalgia 36:1324\u20131333","journal-title":"Cephalalgia"},{"key":"1889_CR148","doi-asserted-by":"publisher","first-page":"1139086","DOI":"10.3389\/fnins.2023.1139086","volume":"17","author":"X Li","year":"2023","unstructured":"Li X, Liu M, Fan W et al (2023) Altered cerebral neurovascular coupling in medication-overuse headache: a study combining multi-modal resting-state fMRI with 3D PCASL. Front Neurosci 17:1139086","journal-title":"Front Neurosci"},{"key":"1889_CR149","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fneur.2018.00576","volume":"9","author":"A Russo","year":"2018","unstructured":"Russo A, Coppola G, Pierelli F et al (2018) Pain perception and migraine. Front Neurol 9:576","journal-title":"Front Neurol"},{"key":"1889_CR150","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1468-2982.2006.01130.x","volume":"26","author":"G Sandrini","year":"2006","unstructured":"Sandrini G, Rossi P, Milanov I et al (2006) Abnormal modulatory influence of diffuse noxious inhibitory controls in migraine and chronic tension-type headache patients. Cephalalgia 26:782\u2013789","journal-title":"Cephalalgia"},{"key":"1889_CR151","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1468-2982.1990.1006273.x","volume":"10","author":"DP Morrison","year":"1990","unstructured":"Morrison DP (1990) Abnormal perceptual experiences in migraine. Cephalalgia 10:273\u2013277","journal-title":"Cephalalgia"},{"key":"1889_CR152","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1212\/WNL.58.3.422","volume":"58","author":"A Shechter","year":"2002","unstructured":"Shechter A, Stewart WF, Silberstein SD et al (2002) Migraine and autonomic nervous system function: a population-based, case-control study. Neurology 58:422\u2013427","journal-title":"Neurology"},{"key":"1889_CR153","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0333102415583989","volume":"36","author":"J Koenig","year":"2016","unstructured":"Koenig J, Williams DP, Kemp AH et al (2016) Vagally mediated heart rate variability in headache patients\u2013a systematic review and meta-analysis. Cephalalgia 36:265\u2013278","journal-title":"Cephalalgia"},{"key":"1889_CR154","doi-asserted-by":"publisher","first-page":"333102423120678","DOI":"10.1177\/03331024231206781","volume":"43","author":"CH Chuang","year":"2023","unstructured":"Chuang CH, Li JY, King JT et al (2023) Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: an exploratory study. Cephalalgia 43:3331024231206781","journal-title":"Cephalalgia"},{"key":"1889_CR155","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0333102420919998","volume":"40","author":"J Hvedstrup","year":"2020","unstructured":"Hvedstrup J, Kolding LT, Ashina M et al (2020) Increased neck muscle stiffness in migraine patients with ictal neck pain: a shear wave elastography study. Cephalalgia 40:565\u2013574","journal-title":"Cephalalgia"},{"key":"1889_CR156","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s10194-018-0913-8","volume":"19","author":"TP Do","year":"2018","unstructured":"Do TP, Heldarskard GF, Kolding LT et al (2018) Myofascial trigger points in migraine and tension-type headache. J Headache Pain 19:84","journal-title":"J Headache Pain"},{"key":"1889_CR157","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1468-2982.2005.00997.x","volume":"26","author":"RB Leistad","year":"2006","unstructured":"Leistad RB, Sand T, Westgaard RH et al (2006) Stress-induced pain and muscle activity in patients with migraine and tension-type headache. Cephalalgia 26:64\u201373","journal-title":"Cephalalgia"},{"key":"1889_CR158","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10194-018-0851-5","volume":"19","author":"K Luedtke","year":"2018","unstructured":"Luedtke K, Mehnert J, May A (2018) Altered muscle activity during rest and during mental or physical activity is not a trait symptom of migraine - a neck muscle EMG study. J Headache Pain 19:26","journal-title":"J Headache Pain"},{"key":"1889_CR159","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/ana.22329","volume":"69","author":"X Zhang","year":"2011","unstructured":"Zhang X, Levy D, Kainz V et al (2011) Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 69:855\u2013865","journal-title":"Ann Neurol"},{"key":"1889_CR160","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1129-2377-14-62","volume":"14","author":"C Costa","year":"2013","unstructured":"Costa C, Tozzi A, Rainero I et al (2013) Cortical spreading depression as a target for anti-migraine agents. J Headache Pain 14:62","journal-title":"J Headache Pain"},{"key":"1889_CR161","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1129-2377-14-65","volume":"14","author":"G Coppola","year":"2013","unstructured":"Coppola G, Di Lorenzo C, Schoenen J et al (2013) Habituation and sensitization in primary headaches. J Headache Pain 14:65","journal-title":"J Headache Pain"},{"key":"1889_CR162","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nlm.2008.07.006","volume":"92","author":"G Coppola","year":"2009","unstructured":"Coppola G, Pierelli F, Schoenen J (2009) Habituation and migraine. Neurobiol Learn Mem 92:249\u2013259","journal-title":"Neurobiol Learn Mem"},{"key":"1889_CR163","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/j.pain.0000000000001151","volume":"159","author":"WT Chen","year":"2018","unstructured":"Chen WT, Hsiao FJ, Ko YC et al (2018) Comparison of somatosensory cortex excitability between migraine and \u201cstrict-criteria\u201d tension-type headache: a magnetoencephalographic study. Pain 159:793\u2013803","journal-title":"Pain"},{"key":"1889_CR164","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/j.pain.0000000000002085","volume":"162","author":"C Abagnale","year":"2021","unstructured":"Abagnale C, Ranieri F, Di Renzo A et al (2021) Impaired short-term visual paired associative plasticity in patients with migraine between attacks. Pain 162:803\u2013810","journal-title":"Pain"},{"key":"1889_CR165","doi-asserted-by":"publisher","first-page":"333102423119578","DOI":"10.1177\/03331024231195780","volume":"43","author":"F Puledda","year":"2023","unstructured":"Puledda F, Vigano A, Sebastianelli G et al (2023) Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: a narrative review. Cephalalgia 43:3331024231195780","journal-title":"Cephalalgia"},{"key":"1889_CR166","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1097\/j.pain.0000000000002255","volume":"162","author":"FJ Hsiao","year":"2021","unstructured":"Hsiao FJ, Chen WT, Liu HY et al (2021) Migraine chronification is associated with beta-band connectivity within the pain-related cortical regions: a magnetoencephalographic study. Pain 162:2590\u20132598","journal-title":"Pain"},{"key":"1889_CR167","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s10194-022-01500-1","volume":"23","author":"FJ Hsiao","year":"2022","unstructured":"Hsiao FJ, Chen WT, Pan LH et al (2022) Resting-state magnetoencephalographic oscillatory connectivity to identify patients with chronic migraine using machine learning. J Headache Pain 23:130","journal-title":"J Headache Pain"},{"key":"1889_CR168","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s10194-023-01677-z","volume":"24","author":"FJ Hsiao","year":"2023","unstructured":"Hsiao FJ, Chen WT, Wu YT et al (2023) Characteristic oscillatory brain networks for predicting patients with chronic migraine. J Headache Pain 24:139","journal-title":"J Headache Pain"},{"key":"1889_CR169","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1129-2377-14-89","volume":"14","author":"A Tessitore","year":"2013","unstructured":"Tessitore A, Russo A, Giordano A et al (2013) Disrupted default mode network connectivity in migraine without aura. J Headache Pain 14:89","journal-title":"J Headache Pain"},{"key":"1889_CR170","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s10194-019-1047-3","volume":"20","author":"K Skorobogatykh","year":"2019","unstructured":"Skorobogatykh K, van Hoogstraten WS, Degan D et al (2019) Functional connectivity studies in migraine: what have we learned? J Headache Pain 20:108","journal-title":"J Headache Pain"},{"key":"1889_CR171","doi-asserted-by":"publisher","first-page":"333102422112827","DOI":"10.1177\/03331024221128278","volume":"43","author":"S Schramm","year":"2023","unstructured":"Schramm S, Borner C, Reichert M et al (2023) Functional magnetic resonance imaging in migraine: a systematic review. Cephalalgia 43:3331024221128278","journal-title":"Cephalalgia"},{"key":"1889_CR172","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/0333102416657146","volume":"37","author":"C Porcaro","year":"2017","unstructured":"Porcaro C, Di Lorenzo G, Seri S et al (2017) Impaired brainstem and thalamic high-frequency oscillatory EEG activity in migraine between attacks. Cephalalgia 37:915\u2013926","journal-title":"Cephalalgia"},{"key":"1889_CR173","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10194-022-01392-1","volume":"23","author":"FJ Hsiao","year":"2022","unstructured":"Hsiao FJ, Chen WT, Pan LH et al (2022) Dynamic brainstem and somatosensory cortical excitability during migraine cycles. J Headache Pain 23:21","journal-title":"J Headache Pain"},{"key":"1889_CR174","first-page":"459","volume":"18","author":"GBD","year":"2016","unstructured":"GBD (2016) Nervous System Disorders Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459\u2013480","journal-title":"Lancet Neurol"},{"key":"1889_CR175","first-page":"1204","volume":"396","author":"GBD","year":"2019","unstructured":"GBD (2019) Nervous System Disorders Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1204\u20131222","journal-title":"Lancet"},{"key":"1889_CR176","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s10194-022-01471-3","volume":"23","author":"C Rosignoli","year":"2022","unstructured":"Rosignoli C, Ornello R, Onofri A et al (2022) Applying a biopsychosocial model to migraine: rationale and clinical implications. J Headache Pain 23:100","journal-title":"J Headache Pain"},{"key":"1889_CR177","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S et al (2021) Diagnosis and management of migraine in ten steps. Nat Revi Neurol 17:501\u2013514","journal-title":"Nat Revi Neurol"},{"key":"1889_CR178","doi-asserted-by":"publisher","first-page":"e010307","DOI":"10.1161\/CIRCOUTCOMES.123.010307","volume":"17","author":"MH Leppert","year":"2024","unstructured":"Leppert MH, Poisson SN, Scarbro S et al (2024) Association of traditional and nontraditional risk factors in the development of strokes among young adults by sex and age group: a retrospective case-control study. Circ Cardiovasc Qual Outcomes 17:e010307","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1889_CR179","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1474-4422(11)70266-6","volume":"11","author":"T Kurth","year":"2012","unstructured":"Kurth T, Chabriat H, Bousser MG (2012) Migraine and stroke: a complex association with clinical implications. Lancet Neurol 11:92\u2013100","journal-title":"Lancet Neurol"},{"key":"1889_CR180","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/brain\/awh542","volume":"128","author":"MC Kruit","year":"2005","unstructured":"Kruit MC, Launer LJ, Ferrari MD et al (2005) Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 128:2068\u20132077","journal-title":"Brain"},{"key":"1889_CR181","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jama.291.4.427","volume":"291","author":"MC Kruit","year":"2004","unstructured":"Kruit MC, van Buchem MA, Hofman PA et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427\u2013434","journal-title":"JAMA"},{"key":"1889_CR182","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1468-2982.2009.01904.x","volume":"30","author":"MC Kruit","year":"2010","unstructured":"Kruit MC, van Buchem MA, Launer LJ et al (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30:129\u2013136","journal-title":"Cephalalgia"},{"key":"1889_CR183","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10194-016-0714-x","volume":"18","author":"A Iwasaki","year":"2017","unstructured":"Iwasaki A, Suzuki K, Takekawa H et al (2017) The relationship between right-to-left shunt and brain white matter lesions in Japanese patients with migraine: a single center study. J Headache Pain 18:3","journal-title":"J Headache Pain"},{"key":"1889_CR184","doi-asserted-by":"publisher","first-page":"e24175","DOI":"10.1097\/MD.0000000000024175","volume":"100","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Liu R, Zhou J et al (2021) Prevalence and grade of RLS in migraine: A prospective study of 251 migraineurs by synchronous test of c-TTE and c-TCD. Medicine (Baltimore) 100:e24175","journal-title":"Medicine (Baltimore)"},{"key":"1889_CR185","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/ene.14284","volume":"27","author":"A Meil\u00e1n","year":"2020","unstructured":"Meil\u00e1n A, Larrosa D, Ram\u00f3n C et al (2020) No association between migraine frequency, white matter lesions and silent brain infarctions: a study in a series of women with chronic migraine. Eur J Neurol 27:1689\u20131696","journal-title":"Eur J Neurol"},{"key":"1889_CR186","doi-asserted-by":"publisher","first-page":"k96","DOI":"10.1136\/bmj.k96","volume":"360","author":"K Adelborg","year":"2018","unstructured":"Adelborg K, Sz\u00e9pligeti SK, Holland-Bill L et al (2018) Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ 360:k96","journal-title":"BMJ"},{"key":"1889_CR187","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1177\/0333102415620909","volume":"36","author":"S Guey","year":"2016","unstructured":"Guey S, Mawet J, Herv\u00e9 D et al (2016) Prevalence and characteristics of migraine in CADASIL. Cephalalgia 36:1038\u20131047","journal-title":"Cephalalgia"},{"key":"1889_CR188","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1177\/0333102418756865","volume":"38","author":"PM Rist","year":"2018","unstructured":"Rist PM, Winter AC, Buring JE et al (2018) Migraine and the risk of incident hypertension among women. Cephalalgia 38:1817\u20131824","journal-title":"Cephalalgia"},{"key":"1889_CR189","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/01.WNL.0000151857.43225.49","volume":"64","author":"AI Scher","year":"2005","unstructured":"Scher AI, Terwindt GM, Picavet HS et al (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64:614\u2013620","journal-title":"Neurology"},{"key":"1889_CR190","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/jnnp-2018-318254","volume":"91","author":"LR \u00d8ie","year":"2020","unstructured":"\u00d8ie LR, Kurth T, Gulati S et al (2020) Migraine and risk of stroke. J Neurol Neurosurg Psychiatry 91:593\u2013604","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1889_CR191","doi-asserted-by":"publisher","first-page":"14069","DOI":"10.1038\/s41598-019-50660-9","volume":"9","author":"FM Filippopulos","year":"2019","unstructured":"Filippopulos FM, Schoeberl F, Becker HC et al (2019) Coronary artery calcification score in migraine patients. Sci Rep 9:14069","journal-title":"Sci Rep"},{"key":"1889_CR192","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1097\/01.hjh.0000239278.82196.a5","volume":"24","author":"SL Wilson","year":"2006","unstructured":"Wilson SL, Poulter NR (2006) The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults. J Hypertens 24:1457\u20131469","journal-title":"J Hypertens"},{"key":"1889_CR193","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jamaneurol.2023.5549","volume":"81","author":"CL Petersen","year":"2024","unstructured":"Petersen CL, Hougaard A, Gaist D et al (2024) Risk of Stroke and Myocardial Infarction Among Initiators of Triptans. JAMA Neurol 81:248\u2013254","journal-title":"JAMA Neurol"},{"key":"1889_CR194","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ana.25831","volume":"88","author":"IA Mulder","year":"2020","unstructured":"Mulder IA, Li M, de Vries T et al (2020) Anti-migraine calcitonin gene-related peptide receptor antagonists worsen cerebral ischemic outcome in mice. Ann Neurol 88:771\u2013784","journal-title":"Ann Neurol"},{"key":"1889_CR195","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s10194-023-01640-y","volume":"24","author":"K Wang","year":"2023","unstructured":"Wang K, Fenton BT, Dao VX et al (2023) Trajectory of blood pressure after initiating anti-calcitonin gene-related peptide treatment of migraine: a target trial emulation from the veterans health administration. J Headache Pain 24:108","journal-title":"J Headache Pain"},{"key":"1889_CR196","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1590\/S2317-17822013000200017","volume":"25","author":"DE Battle","year":"2013","unstructured":"Battle DE (2013) Diagnostic and Statistical Manual of Mental Disorders (DSM). Codas 25:191\u2013192","journal-title":"Codas"},{"key":"1889_CR197","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF00800661","volume":"32","author":"KS Kendler","year":"1997","unstructured":"Kendler KS (1997) The genetic epidemiology of psychiatric disorders: a current perspective. Soc Psychiatry Psychiatr Epidemiol 32:5\u201311","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"1889_CR198","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s42399-023-01622-w","volume":"5","author":"RM Merrill","year":"2023","unstructured":"Merrill RM, Gibbons IS (2023) Comorbidity of sleep disorders, mental illness, and migraine or headaches. SN Compr Clin Med 5:283","journal-title":"SN Compr Clin Med"},{"key":"1889_CR199","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s10194-019-0988-x","volume":"20","author":"T Dresler","year":"2019","unstructured":"Dresler T, Caratozzolo S, Guldolf K et al (2019) Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J Headache Pain 20:51","journal-title":"J Headache Pain"},{"key":"1889_CR200","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jnnp-2015-312233","volume":"87","author":"MT Minen","year":"2016","unstructured":"Minen MT, Begasse De Dhaem O et al (2016) Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry 87:741\u2013749","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1889_CR201","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s10194-022-01388-x","volume":"23","author":"S Giri","year":"2022","unstructured":"Giri S, Tronvik EA, Hagen K (2022) The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies. J Headache Pain 23:14","journal-title":"J Headache Pain"},{"key":"1889_CR202","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","volume":"37","author":"RC Burch","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB (2019) Migraine: epidemiology, burden, and comorbidity. Neurol Clin 37:631\u2013649","journal-title":"Neurol Clin"},{"key":"1889_CR203","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10194-016-0649-2","volume":"17","author":"C Lampl","year":"2016","unstructured":"Lampl C, Thomas H, Tassorelli C et al (2016) Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain 17:59","journal-title":"J Headache Pain"},{"key":"1889_CR204","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11916-018-0668-6","volume":"22","author":"HY Liu","year":"2018","unstructured":"Liu HY, Chou KH, Chen WT (2018) Migraine and the Hippocampus. Curr Pain Headache Rep 22:13","journal-title":"Curr Pain Headache Rep"},{"key":"1889_CR205","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11940-019-0557-2","volume":"21","author":"R Burch","year":"2019","unstructured":"Burch R (2019) Antidepressants for preventive treatment of migraine. Current Treat Options Neurol 21:18","journal-title":"Current Treat Options Neurol"},{"key":"1889_CR206","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/1570159X19666210517150418","volume":"20","author":"TB Jannini","year":"2022","unstructured":"Jannini TB, Lorenzo GD, Bianciardi E et al (2022) Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs). Curr Neuropharmacol 20:693\u2013712","journal-title":"Curr Neuropharmacol"},{"key":"1889_CR207","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1176\/appi.ajp.2018.17111199","volume":"175","author":"K Bromis","year":"2018","unstructured":"Bromis K, Calem M, Reinders A et al (2018) Meta-analysis of 89 structural MRI studies in posttraumatic stress disorder and comparison with major depressive disorder. Am J Psychiatry 175:989\u2013998","journal-title":"Am J Psychiatry"},{"key":"1889_CR208","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/j.1468-2982.2006.01195.x","volume":"26","author":"GG Schoonman","year":"2006","unstructured":"Schoonman GG, Evers DJ, Terwindt GM et al (2006) (2006) The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia 26:1209\u20131213","journal-title":"Cephalalgia"},{"key":"1889_CR209","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/01.WNL.0000052998.58526.A9","volume":"60","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Ruggiero L, Lipton RB et al (2003) Premonitory symptoms in migraine: an electronic diary study. Neurology 60:935\u2013940","journal-title":"Neurology"},{"key":"1889_CR210","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.2147\/JPR.S175602","volume":"11","author":"AB Gago-Veiga","year":"2018","unstructured":"Gago-Veiga AB, Pag\u00e1n J, Henares K et al (2018) To what extent are patients with migraine able to predict attacks? J Pain Res 11:2083\u20132094","journal-title":"J Pain Res"},{"key":"1889_CR211","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2147\/JPR.S337465","volume":"15","author":"YJ Xie","year":"2022","unstructured":"Xie YJ, Lin M, Wong YT et al (2022) Migraine attacks and relevant trigger factors in undergraduate nursing students in hong kong: a cross-sectional study. J Pain Res 15:701\u2013713","journal-title":"J Pain Res"},{"key":"1889_CR212","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/head.12464","volume":"54","author":"RB Lipton","year":"2014","unstructured":"Lipton RB, Pavlovic JM, Haut SR et al (2014) Methodological issues in studying trigger factors and premonitory features of migraine. Headache 54:1661\u20131669","journal-title":"Headache"},{"key":"1889_CR213","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s10194-015-0495-7","volume":"16","author":"LH Schulte","year":"2015","unstructured":"Schulte LH, J\u00fcrgens TP, May A (2015) Photo-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers? J Headache Pain 16:14","journal-title":"J Headache Pain"},{"key":"1889_CR214","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/0333102421997850","volume":"41","author":"X Wang","year":"2021","unstructured":"Wang X, Yin Z, Lian Y et al (2021) Premonitory symptoms in migraine from China: a multi-clinic study of 4821 patients. Cephalalgia 41:991\u20131003","journal-title":"Cephalalgia"},{"key":"1889_CR215","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","volume":"8","author":"MD Ferrari","year":"2022","unstructured":"Ferrari MD, Goadsby PJ, Burstein R et al (2022) Migraine Nat Rev Dis Primers 8:2","journal-title":"Migraine Nat Rev Dis Primers"},{"key":"1889_CR216","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1007\/s00415-023-11706-1","volume":"270","author":"F Puledda","year":"2023","unstructured":"Puledda F, Silva EM, Suwanlaong K et al (2023) Migraine: from pathophysiology to treatment. J Neurol 270:3654\u20133666","journal-title":"J Neurol"},{"key":"1889_CR217","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/head.14308","volume":"62","author":"YH Tu","year":"2022","unstructured":"Tu YH, Wang YF, Yuan H et al (2022) Most bothersome symptoms in patients with migraine: a hospital-based study in Taiwan. Headache 62:596\u2013603","journal-title":"Headache"},{"key":"1889_CR218","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/head.13708","volume":"60","author":"S Munjal","year":"2020","unstructured":"Munjal S, Singh P, Reed ML et al (2020) Most Bothersome symptom in persons with migraine: results from the Migraine in America Symptoms and Treatment (MAST) Study. Headache 60:416\u2013429","journal-title":"Headache"},{"key":"1889_CR219","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/jn.1944.7.6.359","volume":"7","author":"AAP Leao","year":"1944","unstructured":"Leao AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:359\u2013390","journal-title":"J Neurophysiol"},{"issue":"suppl 1","key":"1889_CR220","first-page":"25","volume":"62","author":"MT Gerstein","year":"2022","unstructured":"Gerstein MT, McGinley JS, Houts CR et al (2022) Non-ICHD-3 defning migraine symptoms by phase of the migraine cycle: results of the MiCOAS qualitative study. Headache 62(suppl 1):25","journal-title":"Headache"},{"key":"1889_CR221","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/WCO.0000000000000310","volume":"29","author":"P Bose","year":"2016","unstructured":"Bose P, Goadsby PJ (2016) The migraine postdrome. Curr Opin Neurol 29:299\u2013301","journal-title":"Curr Opin Neurol"},{"key":"1889_CR222","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1212\/CON.0000000000000624","volume":"24","author":"N Karsan","year":"2018","unstructured":"Karsan N, Bose P, Goadsby PJ (2018) The migraine postdrome. Continuum (Minneap Minn) 24:996\u20131008","journal-title":"Continuum (Minneap Minn)"},{"key":"1889_CR223","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/CON.0000000000000983","volume":"27","author":"A Recobe","year":"2021","unstructured":"Recobe A (2021) Pathophysiology of migraine. Continuum (Minneap Minn) 27:586\u2013596","journal-title":"Continuum (Minneap Minn)"},{"key":"1889_CR224","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1001\/jama.2019.16711","volume":"322","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Dodick DW, Ailani J et al (2019) Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial. JAMA 322:1887\u20131898","journal-title":"JAMA"},{"key":"1889_CR225","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2174\/1389557516666160728121050","volume":"17","author":"CM Villal\u00f3n","year":"2017","unstructured":"Villal\u00f3n CM, VanDenBrink AM (2017) The role of 5-hydroxytryptamine in the pathophysiology of migraine and its relevance to the design of novel treatments. Mini Rev Med Chem 17:928\u2013938","journal-title":"Mini Rev Med Chem"},{"key":"1889_CR226","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pharmthera.2018.01.005","volume":"186","author":"E Rubio-Beltr\u00e1n","year":"2018","unstructured":"Rubio-Beltr\u00e1n E, Labastida-Ram\u00edrez A, Villal\u00f3n CM et al (2018) Is selective 5-HT(1F) receptor agonism an entity apart from that of the triptans in antimigraine therapy? Pharmacol Ther 186:88\u201397","journal-title":"Pharmacol Ther"},{"key":"1889_CR227","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(88)92122-8","volume":"1","author":"A Doenicke","year":"1988","unstructured":"Doenicke A, Brand J, Perrin VL (1988) Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1:1309\u20131311","journal-title":"Lancet"},{"key":"1889_CR228","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1111\/bph.14832","volume":"176","author":"E Rubio-Beltr\u00e1n","year":"2019","unstructured":"Rubio-Beltr\u00e1n E, Labastida-Ram\u00edrez A, Haanes KA et al (2019) Characterization of binding, functional activity, and contractile responses of the selective 5-HT(1F) receptor agonist lasmiditan. Br J Pharmacol 176:4681\u20134695","journal-title":"Br J Pharmacol"},{"key":"1889_CR229","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1056\/NEJMct0910887","volume":"363","author":"E Loder","year":"2010","unstructured":"Loder E (2010) Triptan therapy in migraine. N Engl J Med 363:63\u201370","journal-title":"N Engl J Med"},{"key":"1889_CR230","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10194-017-0811-5","volume":"18","author":"S Benemei","year":"2017","unstructured":"Benemei S, Cortese F, Labastida-Ram\u00edrez A et al (2017) Triptans and CGRP blockade - impact on the cranial vasculature. J Headache Pain 18:103","journal-title":"J Headache Pain"},{"issue":"Suppl 4","key":"1889_CR231","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/head.12601","volume":"55","author":"C Cameron","year":"2015","unstructured":"Cameron C, Kelly S, Hsieh SC et al (2015) Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 55(Suppl 4):221\u2013235","journal-title":"Headache"},{"key":"1889_CR232","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","volume":"358","author":"MD Ferrari","year":"2001","unstructured":"Ferrari MD, Roon KI, Lipton RB et al (2001) Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358:1668\u20131675","journal-title":"Lancet"},{"key":"1889_CR233","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.2021.7939","volume":"325","author":"JH VanderPluym","year":"2021","unstructured":"VanderPluym JH, Halker Singh RB, Urtecho M et al (2021) Acute treatments for episodic migraine in adults: a systematic review and meta-analysis. JAMA 325:2357\u20132369","journal-title":"JAMA"},{"key":"1889_CR234","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2165\/00002018-200326020-00003","volume":"26","author":"G Nappi","year":"2003","unstructured":"Nappi G, Sandrini G, Sances G (2003) Tolerability of the triptans: clinical implications. Drug Saf 26:93\u2013107","journal-title":"Drug Saf"},{"key":"1889_CR235","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0333102414550416","volume":"35","author":"G Roberto","year":"2015","unstructured":"Roberto G, Raschi E, Piccinni C et al (2015) Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies. Cephalalgia 35:118\u2013131","journal-title":"Cephalalgia"},{"key":"1889_CR236","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0002-9343(01)01064-6","volume":"112","author":"DG Jamieson","year":"2002","unstructured":"Jamieson DG (2002) The safety of triptans in the treatment of patients with migraine. Am J Med 112:135\u2013140","journal-title":"Am J Med"},{"key":"1889_CR237","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41582-023-00842-x","volume":"19","author":"DD Mitsikostas","year":"2023","unstructured":"Mitsikostas DD, Waeber C, Sanchez-Del-Rio M et al (2023) The 5-HT(1F) receptor as the target of ditans in migraine - from bench to bedside. Nat Rev Neurol 19:489\u2013505","journal-title":"Nat Rev Neurol"},{"key":"1889_CR238","doi-asserted-by":"publisher","first-page":"175628642096784","DOI":"10.1177\/1756286420967847","volume":"13","author":"J Mecklenburg","year":"2020","unstructured":"Mecklenburg J, Raffaelli B, Neeb L et al (2020) The potential of lasmiditan in migraine. Ther Adv Neurol Disord 13:1756286420967847","journal-title":"Ther Adv Neurol Disord"},{"key":"1889_CR239","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/14656566.2017.1361406","volume":"18","author":"B Raffaelli","year":"2017","unstructured":"Raffaelli B, Israel H, Neeb L et al (2017) The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine. Expert Opin Pharmacother 18:1409\u20131415","journal-title":"Expert Opin Pharmacother"},{"key":"1889_CR240","first-page":"270","volume":"253","author":"PJ Goadsby","year":"1987","unstructured":"Goadsby PJ, Duckworth JW (1987) Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am J Physiol 253:270\u2013274","journal-title":"Am J Physiol"},{"key":"1889_CR241","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"1889_CR242","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/0333102418771350","volume":"39","author":"D Levy","year":"2019","unstructured":"Levy D, Labastida-Ramirez A, MaassenVanDenBrink A (2019) Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia 39:1606\u20131622","journal-title":"Cephalalgia"},{"key":"1889_CR243","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","volume":"14","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Haanes KA, Warfvinge K (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 14:338\u2013350","journal-title":"Nat Rev Neurol"},{"key":"1889_CR244","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener H-C, Husstedt IW et al (2004) Calcitonin gene\u2013related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104\u20131110","journal-title":"N Engl J Med"},{"key":"1889_CR245","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/head.13510","volume":"59","author":"R Hargreaves","year":"2019","unstructured":"Hargreaves R, Olesen J (2019) Calcitonin gene-related peptide modulators - the history and renaissance of a new migraine drug class. Headache 59:951\u2013970","journal-title":"Headache"},{"key":"1889_CR246","doi-asserted-by":"publisher","first-page":"333102423115216","DOI":"10.1177\/03331024231152169","volume":"43","author":"R Messina","year":"2023","unstructured":"Messina R, Huessler EM, Puledda F et al (2023) Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: a systematic review and network meta-analysis. Cephalalgia 43:3331024231152169","journal-title":"Cephalalgia"},{"key":"1889_CR247","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s10194-023-01644-8","volume":"24","author":"A Labastida-Ram\u00edrez","year":"2023","unstructured":"Labastida-Ram\u00edrez A, Caronna E, Gollion C et al (2023) Mode and site of action of therapies targeting CGRP signaling. J Headache Pain 24:125","journal-title":"J Headache Pain"},{"key":"1889_CR248","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/bph.15585","volume":"179","author":"ML Garelja","year":"2022","unstructured":"Garelja ML, Walker CS, Hay DL (2022) CGRP receptor antagonists for migraine. Are they also AMY(1) receptor antagonists? Br J Pharmacol 179:454\u2013459","journal-title":"Br J Pharmacol"},{"key":"1889_CR249","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s12031-020-01493-z","volume":"70","author":"L Edvinsson","year":"2020","unstructured":"Edvinsson L, Grell AS, Warfvinge K (2020) Expression of the CGRP family of neuropeptides and their receptors in the trigeminal ganglion. J Mol Neurosci 70:930\u2013944","journal-title":"J Mol Neurosci"},{"key":"1889_CR250","doi-asserted-by":"publisher","first-page":"e2128544","DOI":"10.1001\/jamanetworkopen.2021.28544","volume":"4","author":"CP Yang","year":"2021","unstructured":"Yang CP, Liang CS, Chang CM et al (2021) Comparison of new pharmacologic agents with triptans for treatment of migraine: a systematic review and meta-analysis. JAMA Netw Open 4:e2128544","journal-title":"JAMA Netw Open"},{"key":"1889_CR251","doi-asserted-by":"publisher","first-page":"033310242311514","DOI":"10.1177\/03331024231151419","volume":"43","author":"F Puledda","year":"2023","unstructured":"Puledda F, Younis S, Huessler E-M et al (2023) Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: a systematic review and network meta-analysis of the literature. Cephalalgia 43:03331024231151419","journal-title":"Cephalalgia"},{"key":"1889_CR252","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11916-023-01142-1","volume":"27","author":"D Li","year":"2023","unstructured":"Li D, Abreu J, Tepper SJ (2023) A brief review of gepants. Curr Pain Headache Rep 27:479\u2013488","journal-title":"Curr Pain Headache Rep"},{"key":"1889_CR253","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s40265-018-0923-5","volume":"78","author":"K Maasumi","year":"2018","unstructured":"Maasumi K, Michael RL, Rapoport AM (2018) CGRP and migraine: the role of blocking calcitonin gene-related peptide ligand and receptor in the management of migraine. Drugs 78:913\u2013928","journal-title":"Drugs"},{"key":"1889_CR254","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0165-1838(99)00024-7","volume":"76","author":"J Tajti","year":"1999","unstructured":"Tajti J, Uddman R, M\u00f6ller S et al (1999) Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 76:176\u2013183","journal-title":"J Auton Nerv Syst"},{"key":"1889_CR255","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","volume":"6","author":"TW Ho","year":"2010","unstructured":"Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6:573\u2013582","journal-title":"Nat Rev Neurol"},{"key":"1889_CR256","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10194-009-0112-8","volume":"10","author":"P Tfelt-Hansen","year":"2009","unstructured":"Tfelt-Hansen P, Le H (2009) Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. J Headache Pain 10:137\u2013143","journal-title":"J Headache Pain"},{"key":"1889_CR257","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","volume":"30","author":"JM Hansen","year":"2010","unstructured":"Hansen JM, Hauge AW, Olesen J et al (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30:1179\u20131186","journal-title":"Cephalalgia"},{"key":"1889_CR258","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383:1866\u20131876","journal-title":"N Engl J Med"},{"key":"1889_CR259","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","volume":"381","author":"RB Lipton","year":"2019","unstructured":"Lipton RB, Croop R, Stock EG et al (2019) Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine. N Engl J Med 381:142\u2013149","journal-title":"N Engl J Med"},{"key":"1889_CR260","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","volume":"397","author":"R Croop","year":"2021","unstructured":"Croop R, Lipton RB, Kudrow D et al (2021) Oral rimegepant for preventive treatment of migraine: a phase 2\/3, randomised, double-blind, placebo-controlled trial. Lancet 397:51\u201360","journal-title":"Lancet"},{"key":"1889_CR261","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMoa2035908","volume":"385","author":"J Ailani","year":"2021","unstructured":"Ailani J, Lipton RB, Goadsby PJ et al (2021) Atogepant for the preventive treatment of migraine. N Engl J Med 385:695\u2013706","journal-title":"N Engl J Med"},{"key":"1889_CR262","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0140-6736(23)01049-8","volume":"402","author":"P Pozo-Rosich","year":"2023","unstructured":"Pozo-Rosich P, Ailani J, Ashina M et al (2023) Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 402:775\u2013785","journal-title":"Lancet"},{"key":"1889_CR263","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1474-4422(22)00517-8","volume":"22","author":"RB Lipton","year":"2023","unstructured":"Lipton RB, Croop R, Stock DA et al (2023) Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial. Lancet Neurol 22:209\u2013217","journal-title":"Lancet Neurol"},{"key":"1889_CR264","doi-asserted-by":"publisher","first-page":"333102423115936","DOI":"10.1177\/03331024231159366","volume":"43","author":"F Haghdoost","year":"2023","unstructured":"Haghdoost F, Puledda F, Garcia-Azorin D et al (2023) Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: a systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia 43:3331024231159366","journal-title":"Cephalalgia"},{"key":"1889_CR265","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40120-023-00562-w","volume":"13","author":"TJ Schwedt","year":"2024","unstructured":"Schwedt TJ, Myers Oakes TM, Martinez JM et al (2024) Comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine: results from a randomized, controlled clinical trial. Neurol Ther 13:85\u2013105","journal-title":"Neurol Ther"},{"key":"1889_CR266","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/ph16070934","volume":"16","author":"JB Hong","year":"2023","unstructured":"Hong JB, Lange KS, Overeem LH et al (2023) A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response. Pharmaceuticals (Basel) 16:934","journal-title":"Pharmaceuticals (Basel)"},{"key":"1889_CR267","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10194-023-01552-x","volume":"24","author":"B Raffaelli","year":"2023","unstructured":"Raffaelli B, Fitzek M, Overeem LH et al (2023) Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience. J Headache Pain 24:16","journal-title":"J Headache Pain"},{"key":"1889_CR268","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1212\/WNL.0000000000207292","volume":"101","author":"P Barbanti","year":"2023","unstructured":"Barbanti P, Aurilia C, Egeo G et al (2023) Late response to anti-CGRP monoclonal antibodies in migraine: a multicenter prospective observational study. Neurology 101:482\u2013488","journal-title":"Neurology"},{"key":"1889_CR269","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s10194-023-01698-8","volume":"24","author":"M Waliszewska-Pros\u00f3\u0142","year":"2023","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Vuralli D, Martelletti P (2023) What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants? J Headache Pain 24:163","journal-title":"J Headache Pain"},{"key":"1889_CR270","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","volume":"164","author":"A Miyata","year":"1989","unstructured":"Miyata A, Arimura A, Dahl RR et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567\u2013574","journal-title":"Biochem Biophys Res Commun"},{"key":"1889_CR271","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0006-291X(90)92140-U","volume":"170","author":"A Miyata","year":"1990","unstructured":"Miyata A, Jiang L, Dahl RD et al (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643\u2013648","journal-title":"Biochem Biophys Res Commun"},{"key":"1889_CR272","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283\u2013357","journal-title":"Pharmacol Rev"},{"key":"1889_CR273","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0306-4522(93)90018-B","volume":"57","author":"K Moller","year":"1993","unstructured":"Moller K, Zhang YZ, H\u00e5kanson R et al (1993) Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience 57:725\u2013732","journal-title":"Neuroscience"},{"key":"1889_CR274","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0306-4522(94)90025-6","volume":"63","author":"H Mulder","year":"1994","unstructured":"Mulder H, Uddman R, Moller K et al (1994) Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience 63:307\u2013312","journal-title":"Neuroscience"},{"key":"1889_CR275","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0006-8993(99)01260-3","volume":"826","author":"R Uddman","year":"1999","unstructured":"Uddman R, Tajti J, M\u00f6ller S et al (1999) Neuronal messengers and peptide receptors in the human sphenopalatine and otic ganglia. Brain Res 826:193\u2013199","journal-title":"Brain Res"},{"key":"1889_CR276","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1468-2982.2002.00324.x","volume":"22","author":"R Uddman","year":"2002","unstructured":"Uddman R, Tajti J, Hou M et al (2002) Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 22:112\u2013116","journal-title":"Cephalalgia"},{"key":"1889_CR277","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1016\/0303-7207(94)90212-7","volume":"101","author":"SR Rawlings","year":"1994","unstructured":"Rawlings SR (1994) PACAP, PACAP receptors, and intracellular signalling. Mol Cell Endocrinol 101:C5\u2013C9","journal-title":"Mol Cell Endocrinol"},{"key":"1889_CR278","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00001756-200203250-00030","volume":"13","author":"M Knutsson","year":"2002","unstructured":"Knutsson M, Edvinsson L (2002) Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. NeuroReport 13:507\u2013509","journal-title":"NeuroReport"},{"key":"1889_CR279","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0333102410375624","volume":"31","author":"KY Chan","year":"2011","unstructured":"Chan KY, Baun M, De Vries R et al (2011) Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 31:181\u2013189","journal-title":"Cephalalgia"},{"key":"1889_CR280","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-018-0850-6","volume":"19","author":"JA Waschek","year":"2018","unstructured":"Waschek JA, Baca SM, Akerman S (2018) PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma. J Headache Pain 19:23","journal-title":"J Headache Pain"},{"key":"1889_CR281","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/0333102420975395","volume":"41","author":"NKF Wienholtz","year":"2021","unstructured":"Wienholtz NKF, Christensen CE, Zhang DG et al (2021) Early treatment with sumatriptan prevents PACAP38-induced migraine: a randomised clinical trial. Cephalalgia 41:731\u2013748","journal-title":"Cephalalgia"},{"key":"1889_CR282","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0333102413483931","volume":"33","author":"B Tuka","year":"2013","unstructured":"Tuka B, Helyes Z, Markovics A et al (2013) Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia. 33:1085\u20131095","journal-title":"Cephalalgia."},{"key":"1889_CR283","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/acn3.113","volume":"1","author":"AS Zagami","year":"2014","unstructured":"Zagami AS, Edvinsson L, Goadsby PJ (2014) Pituitary adenylate cyclase activating polypeptide and migraine. Ann Clin Transl Neurol 1:1036\u20131040","journal-title":"Ann Clin Transl Neurol"},{"key":"1889_CR284","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0333102416639517","volume":"37","author":"S Guo","year":"2017","unstructured":"Guo S, Vollesen ALH, Hansen YB et al (2017) Part II: biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients. Cephalalgia 37:136\u2013147","journal-title":"Cephalalgia"},{"key":"1889_CR285","doi-asserted-by":"publisher","first-page":"12302","DOI":"10.1038\/s41598-023-39571-y","volume":"13","author":"S Sbei","year":"2023","unstructured":"Sbei S, Moncrief T, Limjunyawong N et al (2023) PACAP activates MRGPRX2 on meningeal mast cells to drive migraine-like pain. Sci Rep 13:12302","journal-title":"Sci Rep"},{"key":"1889_CR286","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/0333102420970889","volume":"41","author":"M Ashina","year":"2021","unstructured":"Ashina M, Dole\u017eil D, Bonner JH et al (2021) A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. Cephalalgia 41:33\u201344","journal-title":"Cephalalgia"},{"key":"1889_CR287","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s10194-023-01599-w","volume":"24","author":"NB Rasmussen","year":"2023","unstructured":"Rasmussen NB, Deligianni C, Christensen CE et al (2023) The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study. J Headache Pain 24:60","journal-title":"J Headache Pain"},{"key":"1889_CR288","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11916-018-0654-z","volume":"22","author":"L Grazzi","year":"2018","unstructured":"Grazzi L, Sansone M, Rizzoli P (2018) A short review of the Non-invasive transcutaneous pericranial electrical stimulation techniques and their application in headache. Curr Pain Head Rep 22:4","journal-title":"Curr Pain Head Rep"},{"key":"1889_CR289","first-page":"e31223","volume":"14","author":"V Tiwari","year":"2022","unstructured":"Tiwari V, Agrawal S (2022) Migraine and neuromodulation: a literature review. Cureus 14:e31223","journal-title":"Cureus"},{"key":"1889_CR290","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fphar.2019.00032","volume":"10","author":"A Vigan\u00f2","year":"2019","unstructured":"Vigan\u00f2 A, Toscano M, Puledda F et al (2019) Treating chronic migraine with neuromodulation: the role of neurophysiological abnormalities and maladaptive plasticity. Front Pharmacol 10:32","journal-title":"Front Pharmacol"},{"key":"1889_CR291","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2007.06.026","volume":"55","author":"M Hallett","year":"2007","unstructured":"Hallett M (2007) Transcranial magnetic stimulation: a primer. Neuron 55:187\u2013199","journal-title":"Neuron"},{"key":"1889_CR292","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/brain\/aww118","volume":"139","author":"AP Andreou","year":"2016","unstructured":"Andreou AP, Holland PR, Akerman S et al (2016) Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain 139:2002\u20132014","journal-title":"Brain"},{"key":"1889_CR293","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.pain.2014.02.024","volume":"155","author":"G Cosentino","year":"2014","unstructured":"Cosentino G, Fierro B, Vigneri S et al (2014) Cyclical changes of cortical excitability and metaplasticity in migraine: evidence from a repetitive transcranial magnetic stimulation study. Pain 155:1070\u20131078","journal-title":"Pain"},{"key":"1889_CR294","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s10194-020-01204-4","volume":"21","author":"X Moisset","year":"2020","unstructured":"Moisset X, Pereira B, Ciampi De Andrade D et al (2020) Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain 21:142","journal-title":"J Headache Pain"},{"key":"1889_CR295","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.2147\/JPR.S416993","volume":"16","author":"M Shen","year":"2023","unstructured":"Shen M, Li C, Wei X et al (2023) Transcranial magnetic stimulation as a therapy for migraine: an overview of systematic reviews. J Pain Res 16:3133\u20133144","journal-title":"J Pain Res"},{"key":"1889_CR296","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","volume":"9","author":"RB Lipton","year":"2010","unstructured":"Lipton RB, Dodick DW, Silberstein SD et al (2010) Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 9:373\u2013380","journal-title":"Lancet Neurol"},{"key":"1889_CR297","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/AJP.0000000000000071","volume":"30","author":"M De Couck","year":"2014","unstructured":"De Couck M, Nijs J, Gidron Y (2014) You may need a nerve to treat pain: the neurobiological rationale for vagal nerve activation in pain management. Clin J Pain 30:1099\u20131105","journal-title":"Clin J Pain"},{"key":"1889_CR298","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1177\/0333102419833076","volume":"39","author":"DJHA Henssen","year":"2019","unstructured":"Henssen DJHA, Derks B, van Doorn M et al (2019) Vagus nerve stimulation for primary headache disorders: an anatomical review to explain a clinical phenomenon. Cephalalgia 39:1180\u20131194","journal-title":"Cephalalgia"},{"key":"1889_CR299","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s10194-018-0928-1","volume":"19","author":"L Grazzi","year":"2018","unstructured":"Grazzi L, Tassorelli C, de Tommaso M et al (2018) Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial. J Headache Pain 19:98","journal-title":"J Headache Pain"},{"key":"1889_CR300","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","volume":"91","author":"C Tassorelli","year":"2018","unstructured":"Tassorelli C, Grazzi L, de Tommaso M et al (2018) Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology 91:e364\u2013e373","journal-title":"Neurology"},{"key":"1889_CR301","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10194-016-0684-z","volume":"17","author":"L Grazzi","year":"2016","unstructured":"Grazzi L, Egeo G, Calhoun AH et al (2016) Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual\/menstrually related migraine: an open-label study. J Headache Pain 17:91","journal-title":"J Headache Pain"},{"key":"1889_CR302","doi-asserted-by":"publisher","first-page":"1190062","DOI":"10.3389\/fneur.2023.1190062","volume":"14","author":"D Song","year":"2023","unstructured":"Song D, Li P, Wang Y et al (2023) Noninvasive vagus nerve stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials. Front Neurol 14:1190062","journal-title":"Front Neurol"},{"key":"1889_CR303","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/practneurol-2015-001298","volume":"16","author":"S Miller","year":"2016","unstructured":"Miller S, Sinclair AJ, Davies B et al (2016) Neurostimulation in the treatment of primary headaches. Pract Neurol 16:362\u2013375","journal-title":"Pract Neurol"},{"key":"1889_CR304","first-page":"415","volume":"21","author":"CM Ordas","year":"2020","unstructured":"Ordas CM, Cuadrado ML, Pareja JA et al (2020) Transcutaneous supraorbital stimulation as a preventive treatment for chronic migraine: a prospective. Open-Label Study Pain Med 21:415\u2013422","journal-title":"Open-Label Study Pain Med"},{"key":"1889_CR305","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11916-012-0305-8","volume":"217","author":"KL Reed","year":"2013","unstructured":"Reed KL (2013) Peripheral neuromodulation and headaches: clinical approach and considerations on underlying mechanisms. Curr Pain Head Rep 217:305","journal-title":"Curr Pain Head Rep"},{"key":"1889_CR306","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1586\/17434440.2015.1005606","volume":"12","author":"D Magis","year":"2015","unstructured":"Magis D (2015) Neuromodulation in migraine: state of the art and perspectives. Expert Rev Med Devices 12:329\u2013339","journal-title":"Expert Rev Med Devices"},{"key":"1889_CR307","unstructured":"Subramonian A, Argaez C (2020) Non-invasive Nerve Stimulation Modalities for Migraine Pain: A Review of Clinical Effectiveness and Cost-effectiveness. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health"},{"key":"1889_CR308","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fnins.2017.00641","volume":"11","author":"H Thair","year":"2017","unstructured":"Thair H, Holloway AL, Newport R et al (2017) Transcranial Direct Current Stimulation (tDCS): a beginner\u2019s guide for designe and implementation. Front Neurosci 11:641","journal-title":"Front Neurosci"},{"key":"1889_CR309","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.clinph.2013.12.110","volume":"125","author":"S Vigneri","year":"2014","unstructured":"Vigneri S, Bonventre S, Inviati A et al (2014) Effects of transcranial direct current stimulation on esophageal motility in patients with gastroesophageal reflux disease. Clin Neurophysiol 125:1840\u20131846","journal-title":"Clin Neurophysiol"},{"key":"1889_CR310","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2147\/JPR.S295704","volume":"14","author":"G Cai","year":"2021","unstructured":"Cai G, Xia Z, Charvet L et al (2021) A systematic review and meta-analysis on the efficacy of repeated transcranial direct current stimulation for migraine. J Pain Res 14:1171\u20131183","journal-title":"J Pain Res"},{"key":"1889_CR311","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/cns.13843","volume":"28","author":"P Hong","year":"2022","unstructured":"Hong P, Liu Y, Wan Y et al (2022) Transcranial direct current stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials. CNS Neurosci Ther 28:992\u2013998","journal-title":"CNS Neurosci Ther"},{"key":"1889_CR312","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00406-020-01209-9","volume":"271","author":"O Elyamany","year":"2021","unstructured":"Elyamany O, Leicht G, Herrmann CS et al (2021) Transcranial alternating current stimulation (tACS): From basic mechanisms towards first application in psychiatry. Eur Arch Psychiatry Clin Neurosci 271:135\u2013156","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1889_CR313","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/brainsci10110888","volume":"10","author":"A Antal","year":"2020","unstructured":"Antal A, Bischoff R, Stephani C et al (2020) Low intensity, transcranial, alternating current stimulation reduces migraine attack burden in a home application set-up: a double-blinded, randomized feasibility study. Brain Sci 10:888","journal-title":"Brain Sci"},{"issue":"Suppl 1","key":"1889_CR314","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1007\/s10072-013-1360-6","volume":"34","author":"RE Weeks","year":"2013","unstructured":"Weeks RE (2013) Application of behavioral therapies in adult and adolescent patients with chronic migraine. Ital J Neurol Sci 34(Suppl 1):S11\u2013S17","journal-title":"Ital J Neurol Sci"},{"key":"1889_CR315","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s10194-016-0671-4","volume":"17","author":"N Faedda","year":"2016","unstructured":"Faedda N, Cerutti R, Verdecchia P et al (2016) Behavioral management of headache in children and adolescents. J Headache Pain 17:80","journal-title":"J Headache Pain"},{"key":"1889_CR316","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2147\/NDT.S495","volume":"4","author":"MA Kabbouche","year":"2008","unstructured":"Kabbouche MA, Gilman DK (2008) Management of migraine in adolescents. Neuropsychiatr Dis Treat 4:535\u2013548","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1889_CR317","first-page":"9213","volume":"2015","author":"P Harris","year":"2015","unstructured":"Harris P, Loveman E, Clegg A et al (2015) Systematic review of cognitive behavioural therapy for the management of headaches and migraines in adults. Br J Pain 2015:9213\u20139224","journal-title":"Br J Pain"},{"key":"1889_CR318","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jpain.2017.01.002","volume":"18","author":"JW Kroner","year":"2017","unstructured":"Kroner JW, Peugh J, Kashikar-Zuck SM et al (2017) Trajectory of improvement in children and adolescents with chronic migraine: results from the cognitive behavioral therapy and amitriptyline trial. J Pain 18:637\u2013644","journal-title":"J Pain"},{"key":"1889_CR319","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1001\/jama.2013.282533","volume":"310","author":"SW Powers","year":"2013","unstructured":"Powers SW, Kashikar-Zuck SM, Allen JR et al (2013) Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents. JAMA 310:2622\u20132630","journal-title":"JAMA"},{"key":"1889_CR320","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0025-7125(05)70359-X","volume":"85","author":"AE Lake 3rd","year":"2001","unstructured":"Lake AE 3rd (2001) Behavioral and nonpharmacologic treatments of headache. Med Clin North Am 85:1055\u20131075","journal-title":"Med Clin North Am"},{"key":"1889_CR321","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jpain.2014.01.493","volume":"15","author":"E Carpino","year":"2014","unstructured":"Carpino E, Segal S, Logan D et al (2014) The interplay of pain-related self-efficacy and fear on functional outcomes among youth with headache. J Pain 15:527\u2013534","journal-title":"J Pain"},{"key":"1889_CR322","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/JXX.0000000000000323","volume":"33","author":"AL Short","year":"2019","unstructured":"Short AL (2019) Enhancing migraine self-efficacy and reducing disability through a self-management program. J Am Assoc Nurse Pract 33:20\u201328","journal-title":"J Am Assoc Nurse Pract"},{"key":"1889_CR323","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1526-4610.2008.01241.x","volume":"50","author":"SY M\u00e9relle","year":"2010","unstructured":"M\u00e9relle SY, Sorbi MJ, Duivenvoorden HJ et al (2010) Qualities and health of lay trainers with migraine for behavioral attack prevention. Headache 50:613\u2013625","journal-title":"Headache"},{"key":"1889_CR324","first-page":"41","volume":"4","author":"LL Allen","year":"2000","unstructured":"Allen LL, Haririfar M, Cohen J et al (2000) Quality of life and locus of control of migraineurs. Clin Excell Nurse Pract 4:41\u201349","journal-title":"Clin Excell Nurse Pract"},{"key":"1889_CR325","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamainternmed.2020.7090","volume":"181","author":"RE Wells","year":"2021","unstructured":"Wells RE, O\u2019Connell N, Pierce CR et al (2021) Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med 181:317\u2013328","journal-title":"JAMA Intern Med"},{"key":"1889_CR326","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/toxins15020086","volume":"15","author":"L Grazzi","year":"2023","unstructured":"Grazzi L, Montisano DA, Rizzoli P et al (2023) A single-group study on the effect of onabotulinumtoxina in patients with chronic migraine associated with medication overuse headache: pain catastrophizing plays a role. Toxins (Basel) 15:86","journal-title":"Toxins (Basel)"},{"key":"1889_CR327","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.brat.2014.07.009","volume":"61","author":"A Kleiboer","year":"2014","unstructured":"Kleiboer A, Sorbi M, van Silfhout M et al (2014) Short-term effectiveness of an online behavioral training in migraine self-management: a randomized controlled trial. Behav Res Ther 61:61\u201369","journal-title":"Behav Res Ther"},{"key":"1889_CR328","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/head.13337","volume":"56","author":"A Raggi","year":"2018","unstructured":"Raggi A, Grignani E, Leonardi M et al (2018) Behavioral approaches for primary headaches: recent advances. Headache 56:913\u2013925","journal-title":"Headache"},{"key":"1889_CR329","doi-asserted-by":"publisher","unstructured":"Grazzi L, Montisano DA, D\u2019Amico D, et al (2024) Multimodal digital health treatments for Chronic Migraine associated with Medication Overuse Headache: a literature appraisal and results of a single-arm open trial (the BE-HOME program). Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-024-07568-8. Epub ahead of print, May 21, 2024","DOI":"10.1007\/s10072-024-07568-8"},{"key":"1889_CR330","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/brainsci13101432","volume":"13","author":"E Licina","year":"2023","unstructured":"Licina E, Radojicic A, Jeremic M et al (2023) Non-pharmacological treatment of primary headaches-a focused review. Brain Sci 13:1432","journal-title":"Brain Sci"},{"key":"1889_CR331","first-page":"213","volume":"9","author":"B Meyer","year":"2016","unstructured":"Meyer B, Keller A, W\u00f6hlbier HG et al (2016) Progressive muscle relaxation reduces migraine frequency and normalizes amplitudes of contingent negative variation (CNV). J Headache Pain 9:213\u2013224","journal-title":"J Headache Pain"},{"key":"1889_CR332","doi-asserted-by":"publisher","first-page":"780081","DOI":"10.3389\/fnbeh.2021.780081","volume":"15","author":"D Dobos","year":"2022","unstructured":"Dobos D, Szab\u00f3 E, Baksa D et al (2022) Regular practice of autogenic training reduces migraine frequency and is associated with brain activity changes in response to fearful visual stimuli. Front behav neurosci 15:780081","journal-title":"Front behav neurosci"},{"key":"1889_CR333","first-page":"103862","volume":"78","author":"M Aemaz Ur Rehman","year":"2022","unstructured":"Aemaz Ur Rehman M, Waseem R, Habiba U et al (2022) Efficacy of mindfulness-based intervention for the treatment of chronic headaches: a systematic review and meta-analysis. Ann Med Surg (Lond) 78:103862","journal-title":"Ann Med Surg (Lond)"},{"key":"1889_CR334","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/0333102416667023","volume":"36","author":"F Andrasik","year":"2016","unstructured":"Andrasik F, Grazzi L, D\u2019Amico D et al (2016) Mindfulness and headache: a \u201cnew\u201d old treatment, with new findings. Cephalalgia 36:1192\u20131205","journal-title":"Cephalalgia"},{"key":"1889_CR335","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0005-7967(94)E0011-7","volume":"33","author":"JD Teasdale","year":"1995","unstructured":"Teasdale JD, Segal Z, Williams JM (1995) How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help? Behav Res Ther 33:25\u201339","journal-title":"Behav Res Ther"},{"key":"1889_CR336","volume-title":"Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness","author":"J Kabat-Zinn","year":"2013","unstructured":"Kabat-Zinn J (2013) Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. Bantam Books, New York"},{"key":"1889_CR337","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/2156587214543143","volume":"19","author":"M Sharma","year":"2014","unstructured":"Sharma M, Rush SE (2014) Mindfulness-based stress reduction as a stress management intervention for healthy individuals: a systematic review. J Evid Based Complementary Altern Med 19:271\u2013286","journal-title":"J Evid Based Complementary Altern Med"},{"key":"1889_CR338","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.3389\/fpsyg.2017.02350","volume":"8","author":"CQ Zhang","year":"2018","unstructured":"Zhang CQ, Leeming E, Smith P et al (2018) Acceptance and commitment therapy for health behavior change: a contextually-driven approach. Front Psychol 8:2350","journal-title":"Front Psychol"},{"key":"1889_CR339","doi-asserted-by":"publisher","first-page":"106907","DOI":"10.1016\/j.cct.2022.106907","volume":"121","author":"CA Bernstein","year":"2022","unstructured":"Bernstein CA, Connor JP, Vilsmark ES et al (2022) Acceptance and commitment therapy for episodic migraine: rationale and design of a pilot randomized controlled trial. Contemp Clin Trials 121:106907","journal-title":"Contemp Clin Trials"},{"key":"1889_CR340","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/head.14139","volume":"61","author":"L Grazzi","year":"2021","unstructured":"Grazzi L, Andrasik F, Rizzoli P et al (2021) Acceptance and commitment therapy for high frequency episodic migraine without aura: findings from a randomized pilot investigation. Headache 61:895\u2013905","journal-title":"Headache"},{"key":"1889_CR341","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-023-01630-0","volume":"24","author":"L Grazzi","year":"2023","unstructured":"Grazzi L, D\u2019Amico D, Guastafierro E et al (2023) Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). J Headache Pain 24:86","journal-title":"J Headache Pain"},{"key":"1889_CR342","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10194-024-01803-5","volume":"25","author":"D Fedeli","year":"2024","unstructured":"Fedeli D, Ciullo G, Demichelis G et al (2024) Longitudinal neurofunctional changes in medication overuse headache patients after mindfulness practice in a randomized controlled trial (the MIND-CM study). J Headache Pain 25:97","journal-title":"J Headache Pain"},{"key":"1889_CR343","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/14737175.2019.1654859","volume":"19","author":"N Faedda","year":"2019","unstructured":"Faedda N, Natalucci G, Baglioni V et al (2019) Behavioral therapies in headache: focus on mindfulness and cognitive behavioral therapy in children and adolescents. Expert Rev Neurother 19:1219\u20131228","journal-title":"Expert Rev Neurother"},{"key":"1889_CR344","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/NDT.S282565","volume":"17","author":"P Gazerani","year":"2021","unstructured":"Gazerani P (2021) A bidirectional view of migraine and diet relationship. Neuropsychiatr Dis Treat 17:435\u2013451","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1889_CR345","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/WCO.0000000000001204","volume":"36","author":"P Gazerani","year":"2023","unstructured":"Gazerani P (2023) Diet and migraine: what is proven? Curr Opin Neurol 36:615\u2013621","journal-title":"Curr Opin Neurol"},{"key":"1889_CR346","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/nu12061658","volume":"12","author":"P Gazerani","year":"2020","unstructured":"Gazerani P (2020) Migraine and diet. Nutrients 12:1658","journal-title":"Nutrients"},{"issue":"12","key":"1889_CR347","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1177\/0333102415590239","volume":"36","author":"SL Orr","year":"2016","unstructured":"Orr SL (2016) Diet and nutraceutical interventions for headache management: a review of the evidence. Cephalalgia 36(12):1112\u20131133. https:\/\/doi.org\/10.1177\/0333102415590239","journal-title":"Cephalalgia"},{"key":"1889_CR348","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41582-021-00475-y","volume":"17","author":"L Grazzi","year":"2021","unstructured":"Grazzi L, Rizzoli P (2021) Lessons from lockdown \u2014 behavioural interventions in migraine. Nat Rev Neurol 17:195\u2013196","journal-title":"Nat Rev Neurol"},{"key":"1889_CR349","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/ijerph18041503","volume":"18","author":"L Grazzi","year":"2021","unstructured":"Grazzi L, Toppo C, D\u2019Amico D et al (2021) Non-pharmacological approaches to headaches: non-invasive neuromodulation, nutraceuticals, and behavioral approaches. Int J Environ Res Public Health 18:1503","journal-title":"Int J Environ Res Public Health"},{"key":"1889_CR350","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11916-022-01019-9","volume":"26","author":"S Ariyanfar","year":"2022","unstructured":"Ariyanfar S, Razeghi Jahromi S, Togha M et al (2022) Review on headache related to dietary supplements. Curr Pain Headache Rep 26:193\u2013218","journal-title":"Curr Pain Headache Rep"},{"issue":"Suppl 1","key":"1889_CR351","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10072-017-2901-1","volume":"38","author":"F D\u2019Onofrio","year":"2017","unstructured":"D\u2019Onofrio F, Raimo S, Spitaleri D et al (2017) Usefulness of nutraceuticals in migraine prophylaxis. Neurol Sci 38(Suppl 1):117\u2013120","journal-title":"Neurol Sci"},{"key":"1889_CR352","first-page":"e14868","volume":"13","author":"K Kaur","year":"2021","unstructured":"Kaur K, Hernandez V, Al Hajaj SW et al (2021) The efficacy of herbal supplements and nutraceuticals for prevention of migraine: can they help? Cureus 13:e14868","journal-title":"Cureus"},{"key":"1889_CR353","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3390\/nu13082714","volume":"13","author":"L Papetti","year":"2021","unstructured":"Papetti L, Moavero R, Ferilli MAN et al (2021) Truths and myths in pediatric migraine and nutrition. Nutrients 13:2714","journal-title":"Nutrients"},{"key":"1889_CR354","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12883-019-1351-1","volume":"19","author":"C Di Lorenzo","year":"2019","unstructured":"Di Lorenzo C, Coppola G, Bracaglia M et al (2019) A ketogenic diet normalizes interictal cortical but not subcortical responsivity in migraineurs. BMC Neurol 19:136","journal-title":"BMC Neurol"},{"key":"1889_CR355","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/nu11081742","volume":"11","author":"C Di Lorenzo","year":"2019","unstructured":"Di Lorenzo C, Pinto A, Ienca R et al (2019) A randomized double-blind, cross-over trial of very low-calorie diet in overweight migraine patients: a possible role for ketones? Nutrients 11:1742","journal-title":"Nutrients"},{"key":"1889_CR356","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/head.12789","volume":"56","author":"T Rajapakse","year":"2016","unstructured":"Rajapakse T, Pringsheim T (2016) Nutraceuticals in migraine: a summary of existing guidelines for use. Headache 56:808\u2013816","journal-title":"Headache"},{"key":"1889_CR357","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1212\/WNL.50.2.466","volume":"50","author":"J Schoenen","year":"1998","unstructured":"Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466\u2013470","journal-title":"Neurology"},{"key":"1889_CR358","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","volume":"64","author":"PS S\u00e1ndor","year":"2005","unstructured":"S\u00e1ndor PS, Di Clemente L, Coppola G et al (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64:713\u2013715","journal-title":"Neurology"},{"key":"1889_CR359","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/1028415X.2019.1572940","volume":"23","author":"M Parohan","year":"2020","unstructured":"Parohan M, Sarraf P, Javanbakht MH et al (2020) Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials. Nutr Neurosci 23:868\u2013875","journal-title":"Nutr Neurosci"},{"key":"1889_CR360","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/0333102414564891","volume":"35","author":"L Teigen","year":"2015","unstructured":"Teigen L, Boes CJ (2015) An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia 35:912\u2013922","journal-title":"Cephalalgia"},{"key":"1889_CR361","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1212\/01.WNL.0000147290.68260.11","volume":"63","author":"RB Lipton","year":"2004","unstructured":"Lipton RB, G\u00f6bel H, Einh\u00e4upl KM et al (2004) Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology 63:2240\u20132244","journal-title":"Neurology"},{"key":"1889_CR362","doi-asserted-by":"publisher","first-page":"251581631875930","DOI":"10.1177\/2515816318759304","volume":"1","author":"HC Diener","year":"2018","unstructured":"Diener HC, Freitag FG, Danesch U (2018) Safety profile of a special butterbur extract from Petasites hybridus in migraine prevention with emphasis on the liver. Cephalalgia Reports 1:2515816318759304","journal-title":"Cephalalgia Reports"},{"key":"1889_CR363","first-page":"Cd002286","volume":"2004","author":"MH Pittler","year":"2004","unstructured":"Pittler MH, Ernst E (2004) Feverfew for preventing migraine. Cochrane Database Syst Rev. 2004:Cd002286","journal-title":"Cochrane Database Syst Rev."},{"key":"1889_CR364","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1046\/j.1468-2982.2001.218240.x","volume":"21","author":"A Pradalier","year":"2001","unstructured":"Pradalier A, Bakouche P, Baudesson G et al (2001) Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia 21:818\u2013822","journal-title":"Cephalalgia"},{"key":"1889_CR365","doi-asserted-by":"publisher","first-page":"n1448","DOI":"10.1136\/bmj.n1448","volume":"374","author":"CE Ramsden","year":"2021","unstructured":"Ramsden CE, Zamora D, Faurot KR et al (2021) Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial. BMJ 374:n1448","journal-title":"BMJ"},{"key":"1889_CR366","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbi.2024.03.019","volume":"118","author":"HF Wang","year":"2024","unstructured":"Wang HF, Liu WC, Zailani H et al (2024) A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine. Brain Behav Immun 118:459\u2013467","journal-title":"Brain Behav Immun"},{"key":"1889_CR367","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3389\/fneur.2018.00674","volume":"9","author":"D Chirchiglia","year":"2018","unstructured":"Chirchiglia D, Cione E, Caroleo MC et al (2018) Effects of add-on ultramicronized N-palmitol ethanol amide in patients suffering of migraine with aura: a pilot study. Front Neurol 9:674","journal-title":"Front Neurol"},{"key":"1889_CR368","doi-asserted-by":"publisher","first-page":"3938640","DOI":"10.1155\/2020\/3938640","volume":"2020","author":"L Papetti","year":"2020","unstructured":"Papetti L, Sforza G, Tullo G et al (2020) Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study. Pain Res Manag 2020:3938640","journal-title":"Pain Res Manag"},{"issue":"Suppl 1","key":"1889_CR369","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1007\/s10072-011-0522-7","volume":"32","author":"S Usai","year":"2011","unstructured":"Usai S, Grazzi L, Bussone G (2011) Gingkolide B as migraine preventive treatment in young age: results at 1-year follow-up. Neurol Sci 32(Suppl 1):S197\u2013S199","journal-title":"Neurol Sci"},{"key":"1889_CR370","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11916-022-01028-8","volume":"26","author":"A Holdridge","year":"2022","unstructured":"Holdridge A, Donnelly M, Kuruvilla DE (2022) Integrative, interventional, and non-invasive approaches for the treatment for migraine during pregnancy. Curr Pain Headache Rep 26:323\u2013330","journal-title":"Curr Pain Headache Rep"},{"key":"1889_CR371","first-page":"Cd000937","volume":"2014","author":"M Makrides","year":"2014","unstructured":"Makrides M, Crosby DD, Bain E et al (2014) Magnesium supplementation in pregnancy. Cochrane Database Syst Rev. 2014:Cd000937","journal-title":"Cochrane Database Syst Rev."},{"key":"1889_CR372","unstructured":"Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference I, its Panel on Folate OBV, Choline (1998) Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B(6), Folate, Vitamin B(12), Pantothenic Acid, Biotin, and Choline. Washington (DC): National Academies Press. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK114310\/. Accessed 18 July 2024"},{"key":"1889_CR373","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijgo.2008.11.033","volume":"105","author":"E Teran","year":"2009","unstructured":"Teran E, Hernandez I, Nieto B et al (2009) Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet 105:43\u201345","journal-title":"Int J Gynaecol Obstet"},{"key":"1889_CR374","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12906-017-1933-7","volume":"17","author":"A Guilbot","year":"2017","unstructured":"Guilbot A, Bangratz M, Ait Abdellah S et al (2017) A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study. BMC Complement Altern Med 17:433","journal-title":"BMC Complement Altern Med"},{"key":"1889_CR375","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10194-017-0816-0","volume":"18","author":"A Negro","year":"2017","unstructured":"Negro A, Delaruelle Z, Ivanova TA et al (2017) Headache and pregnancy: a systematic review. J Headache Pain 18:106","journal-title":"J Headache Pain"},{"key":"1889_CR376","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3389\/fneur.2019.00771","volume":"10","author":"L Papetti","year":"2019","unstructured":"Papetti L, Ursitti F, Moavero R et al (2019) Prophylactic treatment of pediatric migraine: is there anything new in the last decade? Front Neurol 10:771","journal-title":"Front Neurol"},{"key":"1889_CR377","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1526-4610.2011.01917.x","volume":"51","author":"RE Wells","year":"2011","unstructured":"Wells RE, Bertisch SM, Buettner C et al (2011) Complementary and alternative medicine use among adults with migraines\/severe headaches. Headache 51:1087\u20131097","journal-title":"Headache"},{"key":"1889_CR378","doi-asserted-by":"publisher","first-page":"126","DOI":"10.31083\/j.jin2205126","volume":"22","author":"D Onan","year":"2023","unstructured":"Onan D, Ekizo\u011flu E, Ar\u0131kan H et al (2023) The efficacy of physical therapy and rehabilitation approaches in chronic migraine: a systematic review and meta-analysis. J Integr Neurosci 22:126","journal-title":"J Integr Neurosci"},{"key":"1889_CR379","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/toxins15120685","volume":"15","author":"D Onan","year":"2023","unstructured":"Onan D, Ar\u0131kan H, Martelletti P (2023) The effect of onabotulinumtoxina on headache intensity and number of monthly headache days in individuals with chronic migraine with different levels of neck disability. Toxins (Basel) 15:685","journal-title":"Toxins (Basel)"},{"key":"1889_CR380","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s10194-022-01503-y","volume":"23","author":"YW Woldeamanuel","year":"2022","unstructured":"Woldeamanuel YW, Oliveira ABD (2022) What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain 23:134","journal-title":"J Headache Pain"},{"key":"1889_CR381","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11332-021-00822-y","volume":"18","author":"P Sari Aslani","year":"2022","unstructured":"Sari Aslani P, Hassanpour M, Razi O et al (2022) Resistance training reduces pain indices and improves quality of life and body strength in women with migraine disorders. Sport Sci Health 18:433\u2013443","journal-title":"Sport Sci Health"},{"key":"1889_CR382","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-022-02650-0","volume":"22","author":"MT Benatto","year":"2022","unstructured":"Benatto MT, Florencio LL, Bragatto MM et al (2022) Neck-specific strengthening exercise compared with placebo sham ultrasound in patients with migraine: a randomized controlled trial. BMC Neurol 22:126","journal-title":"BMC Neurol"},{"key":"1889_CR383","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.neurol.2021.06.008","volume":"178","author":"L Sun","year":"2022","unstructured":"Sun L, Li G, Liu F et al (2022) Resistance exercise relieves symptoms of vestibular migraine patients with MRI diagnosis: a randomized parallel-controlled single-blind clinical trial. Rev Neurol (Paris) 178:370\u2013376","journal-title":"Rev Neurol (Paris)"},{"key":"1889_CR384","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-023-01571-8","volume":"24","author":"R La Touche","year":"2023","unstructured":"La Touche R, Fierro-Marrero J, S\u00e1nchez-Ru\u00edz I et al (2023) Prescription of therapeutic exercise in migraine, an evidence-based clinical practice guideline. J Headache Pain 24:68","journal-title":"J Headache Pain"},{"key":"1889_CR385","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10194-011-0314-8","volume":"12","author":"I Rainero","year":"2011","unstructured":"Rainero I, Rubino E, Gallone S et al (2011) Evidence for an association between migraine and the hypocretin receptor 1 gene. J Headache Pain 12:193\u2013199","journal-title":"J Headache Pain"},{"key":"1889_CR386","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1212\/WNL.47.4.1093","volume":"47","author":"H Watanabe","year":"1996","unstructured":"Watanabe H, Kuwabara T, Ohkubo M et al (1996) Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period. Neurology 47:1093\u20131095","journal-title":"Neurology"},{"key":"1889_CR387","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/bjsm.2005.022731","volume":"40","author":"S Jonhagen","year":"2006","unstructured":"Jonhagen S, Ackermann P, Saartok T et al (2006) Calcitonin gene related peptide and neuropeptide Y in skeletal muscle after eccentric exercise: a microdialysis study. Br J Sports Med 40:264\u2013267","journal-title":"Br J Sports Med"},{"key":"1889_CR388","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/JSM.0b013e31817efac9","volume":"18","author":"SM Dittrich","year":"2008","unstructured":"Dittrich SM, G\u00fcnther V, Franz G et al (2008) Aerobic exercise with relaxation: influence on pain and psychological well-being in female migraine patients. Clin J Sport Med 18:363\u2013365","journal-title":"Clin J Sport Med"},{"key":"1889_CR389","doi-asserted-by":"publisher","first-page":"e0163037","DOI":"10.1371\/journal.pone.0163037","volume":"11","author":"A Dinoff","year":"2016","unstructured":"Dinoff A, Herrmann N, Swardfager W et al (2016) The effect of exercise training on resting concentrations of peripheral Brain-Derived Neurotrophic Factor (BDNF): a meta-analysis. PLoS One 11:e0163037","journal-title":"PLoS One"},{"key":"1889_CR390","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s10194-018-0902-y","volume":"19","author":"FM Amin","year":"2018","unstructured":"Amin FM, Aristeidou S, Baraldi C et al (2018) The association between migraine and physical exercise. J Headache Pain 19:83","journal-title":"J Headache Pain"},{"key":"1889_CR391","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1097\/00001756-200312020-00015","volume":"14","author":"PB Sparling","year":"2003","unstructured":"Sparling PB, Giuffrida A, Piomelli D et al (2003) Exercise activates the endocannabinoid system. NeuroReport 14:2209\u20132211","journal-title":"NeuroReport"},{"key":"1889_CR392","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.neurol.2021.07.009","volume":"177","author":"G Demarquay","year":"2021","unstructured":"Demarquay G, Mawet J, Gu\u00e9gan-Massardier E et al (2021) Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment. Rev Neurol (Paris) 177:753\u2013759","journal-title":"Rev Neurol (Paris)"},{"key":"1889_CR393","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-021-01228-4","volume":"22","author":"HW Schytz","year":"2021","unstructured":"Schytz HW, Amin FM, Jensen RH et al (2021) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020. J Headache Pain. 22:22","journal-title":"J Headache Pain."},{"key":"1889_CR394","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/head.13456","volume":"59","author":"American Headache Society","year":"2019","unstructured":"American Headache Society (2019) The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache 59:1\u201318","journal-title":"Headache"},{"key":"1889_CR395","doi-asserted-by":"publisher","first-page":"pzad080","DOI":"10.1093\/ptj\/pzad080","volume":"103","author":"\u00c1 Reina-Varona","year":"2023","unstructured":"Reina-Varona \u00c1, Madro\u00f1ero-Miguel B, Gaul C et al (2023) Therapeutic exercise parameters, considerations, and recommendations for migraine treatment: an international delphi study. Phys Ther. 103:pzad080","journal-title":"Phys Ther."},{"key":"1889_CR396","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12883-017-0835-0","volume":"17","author":"CS Moore","year":"2017","unstructured":"Moore CS, Sibbritt DW, Adams J (2017) A critical review of manual therapy use for headache disorders: prevalence, profiles, motivations, communication and self-reported effectiveness. BMC Neurol 17:61","journal-title":"BMC Neurol"},{"key":"1889_CR397","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/head.13501","volume":"59","author":"PM Rist","year":"2019","unstructured":"Rist PM, Hernandez A, Bernstein C et al (2019) The impact of spinal manipulation on migraine pain and disability: a systematic review and meta-analysis. Headache 59:532\u2013542","journal-title":"Headache"},{"key":"1889_CR398","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10194-011-0296-6","volume":"12","author":"A Chaibi","year":"2011","unstructured":"Chaibi A, Tuchin PJ, Russell MB (2011) Manual therapies for migraine: a systematic review. J Headache Pain 12:127\u2013133","journal-title":"J Headache Pain"},{"key":"1889_CR399","doi-asserted-by":"publisher","first-page":"102386","DOI":"10.1016\/j.msksp.2021.102386","volume":"54","author":"E Mu\u00f1oz-G\u00f3mez","year":"2021","unstructured":"Mu\u00f1oz-G\u00f3mez E, Ingl\u00e9s M, Serra-A\u00f1\u00f3 P et al (2021) Effectiveness of a manual therapy protocol based on articulatory techniques in migraine patients. A randomized controlled trial. Musculoskelet Sci Pract. 54:102386","journal-title":"Musculoskelet Sci Pract."},{"key":"1889_CR400","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.math.2008.09.001","volume":"14","author":"JE Bialosky","year":"2009","unstructured":"Bialosky JE, Bishop MD, Price DD et al (2009) The mechanisms of manual therapy in the treatment of musculoskeletal pain: a comprehensive model. Man Ther 14:531\u2013538","journal-title":"Man Ther"},{"key":"1889_CR401","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.3390\/jcm11164686","volume":"11","author":"E Mu\u00f1oz-G\u00f3mez","year":"2022","unstructured":"Mu\u00f1oz-G\u00f3mez E, Serra-A\u00f1\u00f3 P, Moll\u00e0-Casanova S et al (2022) Potential add-on effects of manual therapy techniques in migraine patients: a randomised controlled trial. J Clin Med 11:4686","journal-title":"J Clin Med"},{"key":"1889_CR402","doi-asserted-by":"publisher","first-page":"102817","DOI":"10.1016\/j.msksp.2023.102817","volume":"66","author":"S Di Antonio","year":"2023","unstructured":"Di Antonio S, Arendt-Nielsen L, Castaldo M (2023) Cervical musculoskeletal impairments and pain sensitivity in migraine patients. Musculoskelet Sci Pract 66:102817","journal-title":"Musculoskelet Sci Pract"},{"key":"1889_CR403","doi-asserted-by":"publisher","first-page":"102800","DOI":"10.1016\/j.msksp.2023.102800","volume":"66","author":"S Di Antonio","year":"2023","unstructured":"Di Antonio S, Arendt-Nielsen L, Ponzano M et al (2023) Migraine patients with and without neck pain: differences in clinical characteristics, sensitization, musculoskeletal impairments, and psychological burden. Musculoskelet Sci Pract 66:102800","journal-title":"Musculoskelet Sci Pract"},{"key":"1889_CR404","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/ptj\/pzz007","volume":"99","author":"TM Szikszay","year":"2019","unstructured":"Szikszay TM, Hoenick S, von Korn K et al (2019) Which examination tests detect differences in cervical musculoskeletal impairments in people with migraine? A systematic review and meta-analysis. Phys Ther 99:549\u2013569","journal-title":"Phys Ther"},{"key":"1889_CR405","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/03331024221082506","volume":"42","author":"S Di Antonio","year":"2022","unstructured":"Di Antonio S, Arendt-Nielsen L, Ponzano M et al (2022) Cervical musculoskeletal impairments in the 4 phases of the migraine cycle in episodic migraine patients. Cephalalgia 42:827\u2013845","journal-title":"Cephalalgia"},{"key":"1889_CR406","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10072-023-07195-9","volume":"45","author":"R Tedeschi","year":"2024","unstructured":"Tedeschi R, Pillastrini P, Pierangeli G et al (2024) Is physiotherapy in migraines known to sufferers? A cross-sectional study. Neurol Sci 45:1669\u20131674","journal-title":"Neurol Sci"},{"key":"1889_CR407","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.apmr.2011.07.198","volume":"92","author":"A Louw","year":"2011","unstructured":"Louw A, Diener I, Butler DS et al (2011) The effect of neuroscience education on pain, disability, anxiety, and stress in chronic musculoskeletal pain. Arch Phys Med Rehabil 92:2041\u20132056","journal-title":"Arch Phys Med Rehabil"},{"key":"1889_CR408","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/pme.12505","volume":"15","author":"P Kindelan-Calvo","year":"2014","unstructured":"Kindelan-Calvo P, Gil-Mart\u00ednez A, Paris-Alemany A et al (2014) Effectiveness of therapeutic patient education for adults with migraine. A systematic review and meta-analysis of randomized controlled trials. Pain Med 15:1619\u20131636","journal-title":"Pain Med"},{"key":"1889_CR409","doi-asserted-by":"publisher","first-page":"333102422114478","DOI":"10.1177\/03331024221144781","volume":"43","author":"R Meise","year":"2023","unstructured":"Meise R, Carvalho GF, Thiel C et al (2023) Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: a randomized controlled trial. Cephalalgia 43:3331024221144781","journal-title":"Cephalalgia"},{"key":"1889_CR410","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1177\/03331024221084217","volume":"42","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2022","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Navarro-Santana MJ, Curiel-Montero F et al (2022) Localized and widespread pressure pain hypersensitivity in patients with episodic or chronic migraine: a systematic review and meta-analysis. Cephalalgia 42:966\u2013980","journal-title":"Cephalalgia"},{"key":"1889_CR411","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s10072-023-07118-8","volume":"45","author":"S Di Antonio","year":"2024","unstructured":"Di Antonio S, Arendt-Nielsen L, Ponzano M et al (2024) Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clusters. Neurol Sci 45:1185\u20131200","journal-title":"Neurol Sci"},{"key":"1889_CR412","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1097\/j.pain.0000000000000602","volume":"157","author":"RR Edwards","year":"2016","unstructured":"Edwards RR, Dworkin RH, Turk DC et al (2016) Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain 157:1851\u20131871","journal-title":"Pain"},{"key":"1889_CR413","unstructured":"World Health Organization (2024) \u201cWhat is Pharmacovigilance?\u201d. Available at: https:\/\/www.who.int\/teams\/regulation-prequalification\/regulation-and-safety\/pharmacovigilance#:~:text=Pharmacovigilance%20is%20the%20science%20and,other%20medicine%2Fvaccine%20related%20problem. Accessed 18 July 2024"},{"key":"1889_CR414","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-022-01424-w","volume":"23","author":"AO G\u00e9rard","year":"2022","unstructured":"G\u00e9rard AO, Merino D, Van Obberghen EK et al (2022) Calcitonin gene-related peptide-targeting drugs and Raynaud\u2019s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database. J Headache Pain 23:53","journal-title":"J Headache Pain"},{"key":"1889_CR415","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/phar.2725","volume":"42","author":"RH Woods","year":"2022","unstructured":"Woods RH (2022) Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: a pharmacovigilance study. Pharmacotherapy 42:758\u2013767","journal-title":"Pharmacotherapy"},{"key":"1889_CR416","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0333102413499649","volume":"34","author":"G Roberto","year":"2014","unstructured":"Roberto G, Piccinni C, D\u2019Alessandro R et al (2014) Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database. Cephalalgia 34:5\u201313","journal-title":"Cephalalgia"},{"key":"1889_CR417","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00228-009-0769-6","volume":"66","author":"F Beau-Salinas","year":"2010","unstructured":"Beau-Salinas F, Jonville-B\u00e9ra AP, Cissoko H et al (2010) Drug dependence associated with triptans and ergot derivatives: a case\/non-case study. Eur J Clin Pharmacol 66:413\u2013417","journal-title":"Eur J Clin Pharmacol"},{"key":"1889_CR418","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1468-2982.2000.00111.x","volume":"20","author":"D Millson","year":"2000","unstructured":"Millson D, Frischer M, Croft P et al (2000) Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Cephalalgia 20:732\u2013737","journal-title":"Cephalalgia"},{"key":"1889_CR419","doi-asserted-by":"publisher","unstructured":"Conijn M, Maas V, van Tuyl M, et al (2024) Breastfeeding-related adverse drug reactions of triptans: a descriptive analysis using four pharmacovigilance databases. Breastfeed Med. https:\/\/doi.org\/10.1089\/bfm.2024.0022. Epub ahead of print, Apr 2, 2024","DOI":"10.1089\/bfm.2024.0022"},{"key":"1889_CR420","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s13311-023-01404-1","volume":"20","author":"D Merino","year":"2023","unstructured":"Merino D, G\u00e9rard AO, Van Obberghen EK et al (2023) The neuropsychiatric safety profile of lasmiditan: a comparative disproportionality analysis with triptans. Neurotherapeutics 20:1305\u20131315","journal-title":"Neurotherapeutics"},{"key":"1889_CR421","doi-asserted-by":"publisher","unstructured":"Wan X, Zhang S, Jiang C, et al (2024) Safety profile of lasmiditan: a retrospective post-marketing pharmacovigilance study based on the real-world data of FAERS database. Expert Opin Drug Saf. https:\/\/doi.org\/10.1080\/14740338.2024.2371382 2024 Epub ahead of print, Jun 20, 2024","DOI":"10.1080\/14740338.2024.2371382"},{"key":"1889_CR422","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/14740338.2023.2223958","volume":"22","author":"V Battini","year":"2023","unstructured":"Battini V, Carnovale C, Clementi E et al (2023) Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System. Expert Opin Drug Saf 22:1105\u20131112","journal-title":"Expert Opin Drug Saf"},{"key":"1889_CR423","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14740338.2023.2251390","volume":"23","author":"B Cao","year":"2024","unstructured":"Cao B, Gu S, Shen Z et al (2024) Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system. Expert Opin Drug Saf 23:297\u2013303","journal-title":"Expert Opin Drug Saf"},{"key":"1889_CR424","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40122-022-00452-3","volume":"12","author":"AM Blumenfeld","year":"2023","unstructured":"Blumenfeld AM, Kaur G, Mahajan A et al (2023) Effectiveness and safety of chronic migraine preventive treatments: a systematic literature review. Pain Ther 12:251\u2013274","journal-title":"Pain Ther"},{"key":"1889_CR425","doi-asserted-by":"publisher","first-page":"820006","DOI":"10.3389\/fphys.2021.820006","volume":"12","author":"P Holzer","year":"2021","unstructured":"Holzer P, Holzer-Petsche U (2021) Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide\u2019s motor-stimulating and prosecretory function in the intestine. Front Physiol 12:820006","journal-title":"Front Physiol"},{"key":"1889_CR426","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425255.2024.2316131","volume":"20","author":"K Ihara","year":"2024","unstructured":"Ihara K, Takizawa T, Watanabe N et al (2024) Potential benefits and possible risks of CGRP-targeted multitherapy in migraine. Expert Opin Drug Metab Toxicol 20:1\u20134","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1889_CR427","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s12325-022-02346-4","volume":"40","author":"SD Silberstein","year":"2023","unstructured":"Silberstein SD, Reshef S, Cohen JM et al (2023) Adverse events reported with therapies targeting the CGRP pathway during the first 6 months post-launch: a retrospective analysis using the FDA adverse events reporting system. Adv Ther 40:445\u2013459","journal-title":"Adv Ther"},{"key":"1889_CR428","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11916-022-01064-4","volume":"26","author":"J Robblee","year":"2022","unstructured":"Robblee J, Harvey LK (2022) Cardiovascular disease and migraine: are the new treatments safe? Curr Pain Headache Rep 26:647\u2013655","journal-title":"Curr Pain Headache Rep"},{"key":"1889_CR429","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/head.14679","volume":"64","author":"N Chhabra","year":"2024","unstructured":"Chhabra N, Mead-Harvey C, Dodoo CA et al (2024) Blood pressure elevation in erenumab-treated patients with migraine: a retrospective real-world experience. Headache 64:233\u2013242","journal-title":"Headache"},{"key":"1889_CR430","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/phar.2706","volume":"42","author":"J Perino","year":"2022","unstructured":"Perino J, Corand V, Laurent E et al (2022) Myocardial infarction associated with erenumab: a case report. Pharmacotherapy 42:585\u2013589","journal-title":"Pharmacotherapy"},{"key":"1889_CR431","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1177\/0333102420983292","volume":"41","author":"R Noseda","year":"2021","unstructured":"Noseda R, Bedussi F, Gobbi C et al (2021) Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: analysis of the WHO pharmacovigilance database. Cephalalgia 41:789\u2013798","journal-title":"Cephalalgia"},{"key":"1889_CR432","doi-asserted-by":"publisher","first-page":"033310242311580","DOI":"10.1177\/03331024231158083","volume":"43","author":"R Noseda","year":"2023","unstructured":"Noseda R, Bedussi F, Gobbi C et al (2023) Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: updated analysis in VigiBase\u00ae. Cephalalgia 43:03331024231158083","journal-title":"Cephalalgia"},{"key":"1889_CR433","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s11096-023-01591-z","volume":"45","author":"L Shafei","year":"2023","unstructured":"Shafei L, Mekki L, Maklad E et al (2023) Factors that influence patient and public adverse drug reaction reporting: a systematic review using the theoretical domains framework. Int J Clin Pharm 45:801\u2013813","journal-title":"Int J Clin Pharm"},{"key":"1889_CR434","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1592\/phco.24.8.743.36068","volume":"24","author":"NR Hartnell","year":"2004","unstructured":"Hartnell NR, Wilson JP (2004) Replication of the weber effect using postmarketing adverse event reports voluntarily submitted to the United States food and drug administration. Pharmacotherapy 24:743\u2013749","journal-title":"Pharmacotherapy"},{"key":"1889_CR435","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10194-011-0388-3","volume":"12","author":"A Negro","year":"2011","unstructured":"Negro A, Martelletti P (2011) Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain 12:593\u2013601","journal-title":"J Headache Pain"},{"key":"1889_CR436","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1468-2982.2006.01172.x","volume":"26","author":"HC Committee","year":"2006","unstructured":"Committee HC, Olesen J, Bousser MG et al (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742\u2013746","journal-title":"Cephalalgia"},{"key":"1889_CR437","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00019052-200206000-00011","volume":"15","author":"K Welch","year":"2002","unstructured":"Welch K, Goadsby P (2002) Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 15:287\u2013295","journal-title":"Curr Opin Neurol"},{"key":"1889_CR438","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s10194-020-01111-8","volume":"21","author":"M Torres-Ferr\u00fas","year":"2020","unstructured":"Torres-Ferr\u00fas M, Ursitti F, Alpuente A et al (2020) From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain 21:42","journal-title":"J Headache Pain"},{"key":"1889_CR439","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/2040622315579627","volume":"6","author":"MW Weatherall","year":"2015","unstructured":"Weatherall MW (2015) The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis 6:115\u2013123","journal-title":"Ther Adv Chronic Dis"},{"key":"1889_CR440","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s10194-024-01755-w","volume":"25","author":"H Gosalia","year":"2024","unstructured":"Gosalia H, Moreno-Ajona D, Goadsby PJ (2024) Medication-overuse headache: a narrative review. J Headache Pain 25:89","journal-title":"J Headache Pain"},{"key":"1889_CR441","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1517\/17425255.2015.1043265","volume":"11","author":"A Ferrari","year":"2015","unstructured":"Ferrari A, Baraldi C, Sternieri E (2015) Medication overuse and chronic migraine: a critical review according to clinical pharmacology. Expert Opin Drug Metab Toxicol 11:1127\u20131144","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1889_CR442","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s10194-024-01712-7","volume":"25","author":"C Tana","year":"2024","unstructured":"Tana C, Raffaelli B, Souza MNP et al (2024) Health equity, care access and quality in headache - part 1. J Headache Pain 25:12","journal-title":"J Headache Pain"},{"key":"1889_CR443","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s10194-023-01699-7","volume":"24","author":"B Raffaelli","year":"2023","unstructured":"Raffaelli B, Rubio-Beltr\u00e1n E, Cho SJ et al (2023) Health equity, care access and quality in headache - part 2. J Headache Pain 24:167","journal-title":"J Headache Pain"},{"key":"1889_CR444","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/head.14732","volume":"64","author":"SC Shao","year":"2024","unstructured":"Shao SC, Hentz J, Shank P et al (2024) Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trial. Headache 64:632\u2013642","journal-title":"Headache"},{"key":"1889_CR445","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s42466-022-00200-0","volume":"4","author":"HC Diener","year":"2022","unstructured":"Diener HC, Kropp P, Dresler T et al (2022) Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline. Neurol Res Pract 4:37","journal-title":"Neurol Res Pract"},{"key":"1889_CR446","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2174\/1381612829666230821092238","volume":"29","author":"C Tana","year":"2023","unstructured":"Tana C, Cipollone F, Giamberardino MA (2023) New therapeutic options for migraine. Curr Pharm Des 29:1964\u20131966","journal-title":"Curr Pharm Des"},{"key":"1889_CR447","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/14728214.2023.2288334","volume":"28","author":"C Tana","year":"2023","unstructured":"Tana C, Cipollone F, Giamberardino MA et al (2023) New drugs targeting calcitonin gene-related peptide for the management of migraines. Expert Opin Emerg Drugs 28:233\u2013240","journal-title":"Expert Opin Emerg Drugs"},{"issue":"Suppl 2","key":"1889_CR448","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/head.12505_2","volume":"55","author":"RB Lipton","year":"2015","unstructured":"Lipton RB, Silberstein SD (2015) Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Headache 55(Suppl 2):103\u2013122","journal-title":"Headache"},{"key":"1889_CR449","first-page":"2133","volume":"403","author":"GBD","year":"2021","unstructured":"GBD (2021) Diseases and Injuries Collaborators (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403:2133\u20132161","journal-title":"Lancet"},{"key":"1889_CR450","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455\u2013464","journal-title":"Nat Rev Neurol"},{"key":"1889_CR451","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/head.13459","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Greisman JD, Baigi K et al (2019) Migraine progression: a systematic review. Headache 59:306\u2013338","journal-title":"Headache"},{"key":"1889_CR452","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s10194-022-01450-8","volume":"23","author":"C Tana","year":"2022","unstructured":"Tana C, Bentivegna E, Cho SJ, Harriott AM et al (2022) Long COVID headache. J Headache Pain 23:93","journal-title":"J Headache Pain"},{"key":"1889_CR453","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/WCO.0000000000001153","volume":"36","author":"C Tana","year":"2023","unstructured":"Tana C, Giamberardino MA, Martelletti P (2023) Long COVID and especially headache syndromes. Curr Opin Neurol 36:168\u2013174","journal-title":"Curr Opin Neurol"},{"key":"1889_CR454","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jiph.2021.04.013","volume":"14","author":"M Waliszewska-Pros\u00f3\u0142","year":"2021","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Budrewicz S (2021) The unusual course of a migraine attack during COVID-19 infection - Case studies of three patients. J Infect Public Health 14:903\u2013905","journal-title":"J Infect Public Health"},{"key":"1889_CR455","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13613-024-01315-0","volume":"14","author":"L Mo\u00efsi","year":"2024","unstructured":"Mo\u00efsi L, Mino JC, Guidet B et al (2024) Frailty assessment in critically ill older adults: a narrative review. Ann Intensive Care 14:93","journal-title":"Ann Intensive Care"},{"key":"1889_CR456","doi-asserted-by":"publisher","first-page":"2265298","DOI":"10.1080\/07853890.2023.2265298","volume":"55","author":"C Tana","year":"2023","unstructured":"Tana C, Moffa L, Falasca K et al (2023) Approach to COVID-19 in older adults and indications for improving the outcomes. Ann Med 55:2265298","journal-title":"Ann Med"},{"key":"1889_CR457","doi-asserted-by":"publisher","first-page":"1348468","DOI":"10.3389\/fmed.2023.1348468","volume":"10","author":"C Tana","year":"2024","unstructured":"Tana C (2024) Editorial: Frailty in older patients during the COVID-19 era. Front Med (Lausanne) 10:1348468","journal-title":"Front Med (Lausanne)"},{"key":"1889_CR458","doi-asserted-by":"publisher","first-page":"104943","DOI":"10.1016\/j.ebiom.2023.104943","volume":"99","author":"R Ornello","year":"2024","unstructured":"Ornello R, Andreou AP, De Matteis E et al (2024) Resistant and refractory migraine: clinical presentation, pathophysiology, and management. EBioMedicine 99:104943","journal-title":"EBioMedicine"},{"key":"1889_CR459","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s10194-020-01130-5","volume":"21","author":"S Sacco","year":"2020","unstructured":"Sacco S, Braschinsky M, Ducros A et al (2020) European headache federation consensus on the definition of resistant and refractory migraine: developed with the endorsement of the European Migraine & Headache Alliance (EMHA). J Headache Pain. 21:76","journal-title":"J Headache Pain."},{"key":"1889_CR460","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.3390\/ijms22115539","volume":"22","author":"M Waliszewska-Pros\u00f3\u0142","year":"2021","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Nowakowska-Kotas M, Chojdak-\u0141ukasiewicz J et al (2021) Migraine and sleep-an unexplained association? Int J Mol Sci 22:5539","journal-title":"Int J Mol Sci"},{"key":"1889_CR461","doi-asserted-by":"publisher","unstructured":"Caronna E, Gallardo VJ, Egeo G, et al (2024) Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2023-333295. Epub ahead of print, May 22, 2024","DOI":"10.1136\/jnnp-2023-333295"},{"key":"1889_CR462","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R et al (2020) Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21:137","journal-title":"J Headache Pain"},{"issue":"6 Suppl 1","key":"1889_CR463","first-page":"S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ et al (2001) Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 56(6 Suppl 1):S20\u2013S28","journal-title":"Neurology"},{"key":"1889_CR464","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2165\/00044011-199815050-00006","volume":"15","author":"SP McKenna","year":"1998","unstructured":"McKenna SP, Doward LC, Davey KM (1998) The Development and Psychometric Properties of the MSQOL: A Migraine-Specific Quality-of-Life Instrument. Clin Drug Investig 15:413\u2013423","journal-title":"Clin Drug Investig"},{"key":"1889_CR465","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12:963\u2013974","journal-title":"Qual Life Res"},{"issue":"Suppl 1","key":"1889_CR466","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10072-018-3373-7","volume":"39","author":"A Raggi","year":"2018","unstructured":"Raggi A, Grazzi L, Grignani E et al (2018) The use of MIDAS in patients with chronic migraine and medication-overuse headache: should we trust it? Neurol Sci 39(Suppl 1):125\u2013127","journal-title":"Neurol Sci"},{"key":"1889_CR467","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1526-4610.2010.01770.x","volume":"50","author":"M Leonardi","year":"2010","unstructured":"Leonardi M, Raggi A, Bussone G et al (2010) Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 50:1576\u20131586","journal-title":"Headache"},{"key":"1889_CR468","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s10194-015-0552-2","volume":"16","author":"J-G Seo","year":"2015","unstructured":"Seo J-G, Park S-P (2015) Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain 16:65","journal-title":"J Headache Pain"},{"key":"1889_CR469","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/ijerph18010246","volume":"18","author":"D D\u2019Amico","year":"2021","unstructured":"D\u2019Amico D, Tepper SJ, Guastafierro E et al (2021) Mapping assessments instruments for headache disorders against the ICF biopsychosocial model of health and disability. Int J Environ Res Public Health 18:246","journal-title":"Int J Environ Res Public Health"},{"key":"1889_CR470","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10194-005-0252-4","volume":"6","author":"M Leonardi","year":"2005","unstructured":"Leonardi M, Steiner TJ, Scher AT et al (2005) The global burden of migraine: measuring disability in headache disorders with WHO\u2019s Classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429\u2013440","journal-title":"J Headache Pain"},{"key":"1889_CR471","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10194-012-0482-1","volume":"13","author":"A Raggi","year":"2012","unstructured":"Raggi A, Giovannetti AM, Quintas R et al (2012) A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 13:595\u2013606","journal-title":"J Headache Pain"},{"key":"1889_CR472","doi-asserted-by":"publisher","first-page":"1090878","DOI":"10.3389\/fneur.2023.1090878","volume":"14","author":"S Duan","year":"2023","unstructured":"Duan S, Ren Z, Xia H et al (2023) Associations between anxiety, depression with migraine, and migraine-related burdens. Front Neurol 14:1090878","journal-title":"Front Neurol"},{"key":"1889_CR473","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10194-017-0742-1","volume":"18","author":"MFP Peres","year":"2017","unstructured":"Peres MFP, Mercante JPP, Tobo PR et al (2017) Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain 18:37","journal-title":"J Headache Pain"},{"key":"1889_CR474","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/jnrp.jnrp_146_18","volume":"10","author":"K Rammohan","year":"2019","unstructured":"Rammohan K, Mundayadan SM, Das S et al (2019) Migraine and mood disorders: prevalence, clinical correlations and disability. J Neurosci Rural Pract 10:28\u201333","journal-title":"J Neurosci Rural Pract"},{"key":"1889_CR475","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/biomedicines12030677","volume":"12","author":"A Della Vecchia","year":"2024","unstructured":"Della Vecchia A, De Luca C, Becattini L et al (2024) Beyond pain relief: unveiling the multifaceted impact of Anti-CGRP\/R mAbs on comorbid symptoms in resistant migraine patients. Biomedicines 12:677","journal-title":"Biomedicines"},{"key":"1889_CR476","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10194-024-01734-1","volume":"25","author":"T Castro Zamparella","year":"2024","unstructured":"Castro Zamparella T, Carpinella M, Peres M et al (2024) Specific cognitive and psychological alterations are more strongly linked to increased migraine disability than chronic migraine diagnosis. J Headache Pain 25:37","journal-title":"J Headache Pain"},{"key":"1889_CR477","doi-asserted-by":"publisher","first-page":"033310242312229","DOI":"10.1177\/03331024231222923","volume":"44","author":"M Torres-Ferr\u00fas","year":"2024","unstructured":"Torres-Ferr\u00fas M, Gallardo VJ, Alpuente A et al (2024) Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies. Cephalalgia 44:03331024231222923","journal-title":"Cephalalgia"},{"key":"1889_CR478","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s10194-021-01369-6","volume":"22","author":"A Stubberud","year":"2021","unstructured":"Stubberud A, Buse DC, Kristoffersen ES et al (2021) Is there a causal relationship between stress and migraine? Current evidence and implications for management. J Headache Pain 22:155","journal-title":"J Headache Pain"},{"key":"1889_CR479","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s10194-005-0240-8","volume":"6","author":"P Perozzo","year":"2005","unstructured":"Perozzo P, Savi L, Castelli L et al (2005) Anger and emotional distress in patients with migraine and tension-type headache. J Headache Pain 6:392\u2013399","journal-title":"J Headache Pain"},{"key":"1889_CR480","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jocn.2018.01.032","volume":"50","author":"JG Seo","year":"2018","unstructured":"Seo JG, Park SP (2018) Significance of fatigue in patients with migraine. J Clin Neurosci 50:69\u201373","journal-title":"J Clin Neurosci"},{"key":"1889_CR481","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1468-2982.2007.01367.x","volume":"27","author":"JC Garcia-Monco","year":"2007","unstructured":"Garcia-Monco JC, Foncea N, Bilbao A et al (2007) Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients. Cephalalgia 27:920\u2013928","journal-title":"Cephalalgia"},{"key":"1889_CR482","doi-asserted-by":"publisher","first-page":"955298","DOI":"10.3389\/fneur.2022.955298","volume":"13","author":"S Duan","year":"2022","unstructured":"Duan S, Ren Z, Xia H et al (2022) Association between sleep quality, migraine and migraine burden. Front Neurol 13:955298","journal-title":"Front Neurol"},{"key":"1889_CR483","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s10194-020-01192-5","volume":"21","author":"C Tiseo","year":"2020","unstructured":"Tiseo C, Vacca A, Felbush A et al (2020) Migraine and sleep disorders: a systematic review. J Headache Pain 21:126","journal-title":"J Headache Pain"},{"key":"1889_CR484","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s10194-005-0201-2","volume":"6","author":"S Gori","year":"2005","unstructured":"Gori S, Morelli N, Maestri M et al (2005) Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. J Headache Pain 6:258\u2013260","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"1889_CR485","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10072-014-1736-2","volume":"35","author":"A Raggi","year":"2014","unstructured":"Raggi A, Covelli V, Leonardi M et al (2014) Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review. Neurol Sci 35(Suppl 1):23\u201326","journal-title":"Neurol Sci"},{"key":"1889_CR486","first-page":"197","volume":"29","author":"RE Shapiro","year":"2023","unstructured":"Shapiro RE, Martin AA, Bhardwaj S et al (2023) Relationships between headache frequency, disability, and disability-related unemployment among adults with migraine. J Manag Care Spec Pharm 29:197\u2013209","journal-title":"J Manag Care Spec Pharm"},{"key":"1889_CR487","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-019-1044-6","volume":"20","author":"RE Shapiro","year":"2019","unstructured":"Shapiro RE, Hochstetler HM, Dennehy EB et al (2019) Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials. J Headache Pain 20:90","journal-title":"J Headache Pain"},{"key":"1889_CR488","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-024-01740-3","volume":"25","author":"D Garc\u00eda-Azor\u00edn","year":"2024","unstructured":"Garc\u00eda-Azor\u00edn D, Moya-Alarc\u00f3n C, Armada B et al (2024) Societal and economic burden of migraine in Spain: results from the 2020 National Health and Wellness Survey. J Headache Pain 25:38","journal-title":"J Headache Pain"},{"key":"1889_CR489","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-020-01110-9","volume":"21","author":"L Lombard","year":"2020","unstructured":"Lombard L, Farrar M, Ye W et al (2020) A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication. J Headache Pain 21:41","journal-title":"J Headache Pain"},{"key":"1889_CR490","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40359-023-01207-1","volume":"11","author":"L Woodland","year":"2023","unstructured":"Woodland L, Brooks SK, Webster RK et al (2023) Risk factors for school-based presenteeism in children: a systematic review. BMC Psychology 11:169","journal-title":"BMC Psychology"},{"key":"1889_CR491","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/B978-0-12-823356-6.00015-9","volume":"198","author":"M Leonardi","year":"2023","unstructured":"Leonardi M, Guastafierro E, Toppo C et al (2023) Societal and personal impact of migraine. Handb Clin Neurol 198:23\u201329","journal-title":"Handb Clin Neurol"},{"key":"1889_CR492","first-page":"A08200592","volume":"68","author":"AH Snoer","year":"2021","unstructured":"Snoer AH, H\u00f8st C, D\u00f8mgaard M et al (2021) Frequent or chronic migraine negatively impacts personal, social and professional life. Dan Med J 68:A08200592","journal-title":"Dan Med J"},{"key":"1889_CR493","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1177\/03331024211027568","volume":"41","author":"C Cerami","year":"2021","unstructured":"Cerami C, Crespi C, Bottiroli S et al (2021) High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: a cross sectional survey on chronic and episodic patients. Cephalalgia 41:1437\u20131446","journal-title":"Cephalalgia"},{"key":"1889_CR494","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s10194-021-01224-8","volume":"22","author":"TT Takahashi","year":"2021","unstructured":"Takahashi TT, Ornello R, Quatrosi G et al (2021) (2021) Medication overuse and drug addiction: a narrative review from addiction perspective. J Headache Pain 22:32","journal-title":"J Headache Pain"},{"key":"1889_CR495","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1468-2982.2007.01462.x","volume":"28","author":"K M\u00e4ki","year":"2008","unstructured":"M\u00e4ki K, Vahtera J, Virtanen M et al (2008) Work stress and new-onset migraine in a female employee population. Cephalalgia 28:18\u201325","journal-title":"Cephalalgia"},{"key":"1889_CR496","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.3390\/ijerph16183341","volume":"16","author":"I Berardelli","year":"2019","unstructured":"Berardelli I, Sarubbi S, Lamis DA et al (2019) Job satisfaction mediates the association between perceived disability and work productivity in migraine headache patients. Int J Environ Res Public Health 16:3341","journal-title":"Int J Environ Res Public Health"},{"key":"1889_CR497","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s10194-015-0585-6","volume":"16","author":"WY Kuo","year":"2015","unstructured":"Kuo WY, Huang CC, Weng SF et al (2015) Higher migraine risk in healthcare professionals than in general population: a nationwide population-based cohort study in Taiwan. J Headache Pain 16:102","journal-title":"J Headache Pain"},{"key":"1889_CR498","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s10194-023-01591-4","volume":"24","author":"D Wei","year":"2023","unstructured":"Wei D, Loganathan T, Wong LP (2023) Employees of the banking sector in Guizhou Province in China: prevalence of migraine, symptoms, disability and occupational risk factors. J Headache Pain 24:52","journal-title":"J Headache Pain"},{"key":"1889_CR499","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/head.13622","volume":"59","author":"CH Sandoe","year":"2019","unstructured":"Sandoe CH, Sasikumar S, Lay C et al (2019) The impact of shift work on migraine: a case series and narrative review. Headache 59:1631\u20131640","journal-title":"Headache"},{"key":"1889_CR500","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10194-020-1075-z","volume":"21","author":"W Xie","year":"2020","unstructured":"Xie W, Li R, He M et al (2020) Prevalence and risk factors associated with headache amongst medical staff in South China. J Headache Pain. 21:5","journal-title":"J Headache Pain."},{"key":"1889_CR501","doi-asserted-by":"publisher","first-page":"e12328","DOI":"10.1002\/1348-9585.12328","volume":"64","author":"K Suzuki","year":"2022","unstructured":"Suzuki K, Okamura M, Haruyama Y et al (2022) Exploring the contributing factors to multiple chemical sensitivity in patients with migraine. J Occup Health 64:e12328","journal-title":"J Occup Health"},{"key":"1889_CR502","doi-asserted-by":"publisher","first-page":"72","DOI":"10.36469\/jheor.2023.87790","volume":"10","author":"R Martins","year":"2023","unstructured":"Martins R, Large S, Russell R et al (2023) The hidden economic consequences of migraine to the UK Government: burden-of-disease analysis using a fiscal framework. J Health Econ Outcomes Res 10:72\u201381","journal-title":"J Health Econ Outcomes Res"},{"key":"1889_CR503","doi-asserted-by":"publisher","first-page":"100408","DOI":"10.1016\/j.ensci.2022.100408","volume":"27","author":"O Begasse de Dhaem","year":"2022","unstructured":"Begasse de Dhaem O, Sakai F (2022) Migraine in the workplace. eNeurologicalSci 27:100408","journal-title":"eNeurologicalSci"},{"key":"1889_CR504","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2165\/00019053-200119020-00006","volume":"19","author":"WC Gerth","year":"2001","unstructured":"Gerth WC, Carides GW, Dasbach EJ et al (2001) The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics 19:197\u2013206","journal-title":"Pharmacoeconomics"},{"key":"1889_CR505","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353\u2013365","journal-title":"Pharmacoeconomics"},{"key":"1889_CR506","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s10194-018-0914-7","volume":"19","author":"A Raggi","year":"2018","unstructured":"Raggi A, Covelli V, Guastafierro E et al (2018) Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire. J Headache Pain 19:85","journal-title":"J Headache Pain"},{"key":"1889_CR507","doi-asserted-by":"publisher","first-page":"333102423116568","DOI":"10.1177\/03331024231165682","volume":"43","author":"F Sakai","year":"2023","unstructured":"Sakai F, Igarashi H, Yokoyama M et al (2023) Diagnosis, knowledge, perception, and productivity impact of headache education and clinical evaluation program in the workplace at an information technology company of more than 70,000 employees. Cephalalgia 43:3331024231165682","journal-title":"Cephalalgia"},{"key":"1889_CR508","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1185\/030079904X10151","volume":"20","author":"T Vicente-Herrero","year":"2004","unstructured":"Vicente-Herrero T, Burke TA, La\u00ednez MJ (2004) The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective. Curr Med Res Opin 20:1805\u20131814","journal-title":"Curr Med Res Opin"},{"key":"1889_CR509","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.jom.0000105907.85479.3e","volume":"46","author":"WC Gerth","year":"2004","unstructured":"Gerth WC, Sarma S, Hu XH et al (2004) Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model. J Occup Environ Med 46:48\u201354","journal-title":"J Occup Environ Med"},{"key":"1889_CR510","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/medicina58050686","volume":"58","author":"M Ricc\u00f2","year":"2022","unstructured":"Ricc\u00f2 M, Ferraro P, Camisa V et al (2022) Managing of migraine in the workplaces: knowledge, attitudes and practices of italian occupational physicians. Medicina (Kaunas) 58:686","journal-title":"Medicina (Kaunas)"},{"key":"1889_CR511","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1177\/0333102415604471","volume":"36","author":"R Gil-Gouveia","year":"2016","unstructured":"Gil-Gouveia R, Oliveira AG, Martins IP (2016) The impact of cognitive symptoms on migraine attack-related disability. Cephalalgia 36:422\u2013430","journal-title":"Cephalalgia"},{"key":"1889_CR512","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12995-016-0115-8","volume":"11","author":"X Fan","year":"2016","unstructured":"Fan X, Els C, Corbet KJ et al (2016) \u201cDecision-critical\u201d work: a conceptual framework. J Occup Med Toxicol 11:22","journal-title":"J Occup Med Toxicol"},{"key":"1889_CR513","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/jgs.18719","volume":"72","author":"CG DiGuiseppi","year":"2024","unstructured":"DiGuiseppi CG, Johnson RL, Betz ME (2024) Migraine headaches are associated with motor vehicle crashes and driving habits among older drivers: Prospective cohort study. J Am Geriatr Soc 72:791\u2013801","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 1","key":"1889_CR514","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/head.13301","volume":"58","author":"R Agosti","year":"2018","unstructured":"Agosti R (2018) Migraine burden of disease: from the patient\u2019s experience to a socio-economic view. Headache 58(Suppl 1):17\u201332","journal-title":"Headache"},{"key":"1889_CR515","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10194-012-0460-7","volume":"13","author":"LM Bloudek","year":"2012","unstructured":"Bloudek LM, Stokes M, Buse DC et al (2012) Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain 13:361\u2013378","journal-title":"J Headache Pain"},{"key":"1889_CR516","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13561-023-00459-2","volume":"13","author":"A Eltrafi","year":"2023","unstructured":"Eltrafi A, Shrestha S, Ahmed A et al (2023) Economic burden of chronic migraine in OECD countries: a systematic review. Health Econ Rev 13:43","journal-title":"Health Econ Rev"},{"key":"1889_CR517","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s10194-023-01546-9","volume":"24","author":"A Hus\u00f8y","year":"2023","unstructured":"Hus\u00f8y A, Katsarava Z, Steiner TJ (2023) The relationship between headache-attributed disability and lost productivity: 3 Attack frequency is the dominating variable. J Headache Pain 24:7","journal-title":"J Headache Pain"},{"key":"1889_CR518","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s10194-015-0574-9","volume":"16","author":"GN Rao","year":"2015","unstructured":"Rao GN, Kulkarni GB, Gururaj G et al (2015) The burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State. J Headache Pain 16:94","journal-title":"J Headache Pain"},{"key":"1889_CR519","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1111\/head.13969","volume":"60","author":"S Tu","year":"2020","unstructured":"Tu S, Liew D, Ademi Z et al (2020) The Health and Productivity Burden of Migraines in Australia. Headache 60:2291\u20132303","journal-title":"Headache"},{"key":"1889_CR520","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10194-021-01265-z","volume":"22","author":"TJ Steiner","year":"2021","unstructured":"Steiner TJ, Jensen R, Katsarava Z (2021) Structured headache services as the solution to the ill-health burden of headache. 1. Rationale and description. J Headache Pain. 22:78","journal-title":"J Headache Pain."},{"key":"1889_CR521","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10194-021-01310-x","volume":"22","author":"M Tinelli","year":"2021","unstructured":"Tinelli M, Leonardi M, Paemeleire K et al (2021) Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology. J Headache Pain. 22:99","journal-title":"J Headache Pain."},{"key":"1889_CR522","unstructured":"World Health Organization (2011) Atlas of headache disorders and resources in the World 2011. World Health Organization; Geneva. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789241564212. Accessed 18 July 2024"},{"issue":"4","key":"1889_CR523","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E (2018) The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 58(4):496\u2013505","journal-title":"Headache."},{"key":"1889_CR524","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1526-4610.2008.01282.x","volume":"49","author":"BW Friedman","year":"2009","unstructured":"Friedman BW, Serrano D, Reed M et al (2009) Use of the emergency department for severe headache. A population-based study. Headache 49:21\u201330","journal-title":"Headache"},{"key":"1889_CR525","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1212\/WNL.0b013e3181c34abb","volume":"73","author":"Z Katsarava","year":"2009","unstructured":"Katsarava Z, Dzagnidze A, Kukava M et al (2009) Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology 73:1796\u20131803","journal-title":"Neurology"},{"key":"1889_CR526","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/0333102412438977","volume":"32","author":"I Ayzenberg","year":"2012","unstructured":"Ayzenberg I, Katsarava Z, Sborowski A et al (2012) The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32:373\u2013381","journal-title":"Cephalalgia"},{"key":"1889_CR527","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1177\/03331024221093623","volume":"42","author":"M Lisicki","year":"2022","unstructured":"Lisicki M, Souza MNP, de Oliveira AB et al (2022) Bridging the gaps of headache care for underserved populations: current status of the headache field in Latin America. Cephalalgia 42:1086\u20131090","journal-title":"Cephalalgia"},{"key":"1889_CR528","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-015-0515-7","volume":"16","author":"E Mbewe","year":"2015","unstructured":"Mbewe E, Zairemthiama P, Yeh HH et al (2015) The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J Headache Pain 16:30","journal-title":"J Headache Pain"},{"key":"1889_CR529","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10194-016-0704-z","volume":"17","author":"M Zebenigus","year":"2016","unstructured":"Zebenigus M, Tekle-Haimanot R, Worku DK (2016) The prevalence of primary headache disorders in Ethiopia. J Headache Pain 17:110","journal-title":"J Headache Pain"},{"key":"1889_CR530","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/head.12406","volume":"54","author":"ED Mauser","year":"2014","unstructured":"Mauser ED, Rosen NL (2014) So many migraines, so few subspecialists: analysis of the geographic location of United Council for Neurologic Subspecialties (UCNS) certified headache subspecialists compared to United States headache demographics. Headache 54:1347\u20131357","journal-title":"Headache"},{"key":"1889_CR531","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11916-019-0749-1","volume":"23","author":"U Najib","year":"2019","unstructured":"Najib U, Moore M, Watson D (2019) Unique considerations for special populations in episodic migraine: the underserved. Curr Pain Headache Rep 23:9","journal-title":"Curr Pain Headache Rep"},{"key":"1889_CR532","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/head.13286","volume":"58","author":"L Charleston","year":"2018","unstructured":"Charleston L, Royce J, Monteith TS et al (2018) Migraine care challenges and strategies in US uninsured and underinsured adults: a narrative review, part 1. Headache 58:506\u2013511","journal-title":"Headache"},{"key":"1889_CR533","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/head.13321","volume":"58","author":"L Charleston","year":"2018","unstructured":"Charleston L, Royce J, Monteith TS et al (2018) Migraine care challenges and strategies in US uninsured and underinsured adults: a narrative review, part 2. Headache 58:633\u2013647","journal-title":"Headache"},{"key":"1889_CR534","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP et al (2021) Migraine: epidemiology and systems of care. Lancet 397:1485\u20131495","journal-title":"Lancet"},{"key":"1889_CR535","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1129-2377-14-47","volume":"14","author":"R Liu","year":"2013","unstructured":"Liu R, Yu S, He M et al (2013) Health-care utilization for primary headache disorders in China: a population-based door-to-door survey. J Headache Pain 14:47","journal-title":"J Headache Pain"},{"key":"1889_CR536","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S1474-4422(04)00855-5","volume":"3","author":"K Ravishankar","year":"2004","unstructured":"Ravishankar K (2004) Barriers to headache care in India and efforts to improve the situation. Lancet Neurol 3:564\u2013567","journal-title":"Lancet Neurol"},{"key":"1889_CR537","unstructured":"Armand CE, Borrero-Mejias C, Pace A, et al (2023) Update on Underrepresented Populations in Headache Medicine: What Is Known and Care Considerations. Pract Neurol. Available at: https:\/\/practicalneurology.com\/articles\/2023-may-june\/update-on-underrepresented-populations-in-headache-medicine-what-is-known-and-care-considerations. Accessed 18 July 2024"},{"key":"1889_CR538","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1468-2982.2007.01397.x","volume":"27","author":"J Olesen","year":"2007","unstructured":"Olesen J, Lekander I, Andlin-Sobocki P et al (2007) Funding of headache research in Europe. Cephalalgia 27:995\u2013999","journal-title":"Cephalalgia"},{"issue":"9","key":"1889_CR539","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1468-2982.2007.01396.x","volume":"27","author":"R Shapiro","year":"2007","unstructured":"Shapiro R, Goadsby P (2007) The long drought: the dearth of public funding for headache research. Cephalalgia 27(9):991\u2013994","journal-title":"Cephalalgia"},{"key":"1889_CR540","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11916-018-0731-3","volume":"22","author":"DR Befus","year":"2018","unstructured":"Befus DR, Irby MB, Coeytaux RR et al (2018) A critical exploration of migraine as a health disparity: the imperative of an equity-oriented, intersectional approach. Curr Pain Headache Rep 22:79","journal-title":"Curr Pain Headache Rep"},{"key":"1889_CR541","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s42399-021-00868-6","volume":"3","author":"AG Voloshin","year":"2021","unstructured":"Voloshin AG, Moiseeva IV (2021) Combined Interventional treatment of refractory chronic migraine. SN Compr Clin Med 3:1320\u20131326","journal-title":"SN Compr Clin Med"},{"key":"1889_CR542","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s10194-022-01502-z","volume":"23","author":"S Sacco","year":"2022","unstructured":"Sacco S, Lampl C, Amin FM et al (2022) European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure. J Headache Pain 23:133","journal-title":"J Headache Pain"},{"key":"1889_CR543","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s42399-022-01279-x","volume":"4","author":"R Meise","year":"2022","unstructured":"Meise R, Schwarz A, Luedtke K (2022) Effectiveness of patient education and cognitive behavioural treatment as a non-pharmacological intervention for migraine in adults \u2013 a systematic review. SN Compr Clin Med 4:197","journal-title":"SN Compr Clin Med"},{"key":"1889_CR544","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1111\/ene.15391","volume":"29","author":"CLA Bassetti","year":"2022","unstructured":"Bassetti CLA, Endres M, Sander A et al (2022) The European Academy of Neurology Brain Health Strategy: One brain, one life, one approach. Eur J Neurol 29:2559\u20132566","journal-title":"Eur J Neurol"},{"key":"1889_CR545","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s10194-024-01795-2","volume":"25","author":"TJ Steiner","year":"2024","unstructured":"Steiner TJ, Hus\u00f8y A, Stovner LJ (2024) GBD2021: headache disorders and global lost health \u2013 a focus on children, and a view forward. J Headache Pain 25:91","journal-title":"J Headache Pain"},{"key":"1889_CR546","first-page":"351","volume":"29","author":"BC Choi","year":"2006","unstructured":"Choi BC, Pak AW (2006) Multidisciplinarity, interdisciplinarity and transdisciplinarity in health research, services, education and policy: 1. Definitions, objectives, and evidence of effectiveness. Clin Invest Med 29:351\u2013364","journal-title":"Clin Invest Med"},{"key":"1889_CR547","doi-asserted-by":"publisher","first-page":"E224","DOI":"10.25011\/cim.v30i6.2950","volume":"30","author":"BC Choi","year":"2007","unstructured":"Choi BC, Pak AW (2007) Multidisciplinarity, interdisciplinarity, and transdisciplinarity in health research, services, education and policy: 2. Promotors, barriers, and strategies of enhancement. Clin Invest Med 30:E224\u2013E232","journal-title":"Clin Invest Med"},{"key":"1889_CR548","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.25011\/cim.v31i1.3140","volume":"31","author":"BC Choi","year":"2008","unstructured":"Choi BC, Pak AW (2008) Multidisciplinarity, interdisciplinarity, and transdisciplinarity in health research, services, education and policy: 3. Discipline, inter-discipline distance, and selection of discipline. Clin Invest Med 31:E41\u2013E48","journal-title":"Clin Invest Med"},{"key":"1889_CR549","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s42005-021-00769-z","volume":"4","author":"Y Sun","year":"2021","unstructured":"Sun Y, Livan G, Ma A et al (2021) Interdisciplinary researchers attain better long-term funding performance. Commun Phys 4:263","journal-title":"Commun Phys"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01889-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T01:17:21Z","timestamp":1757121441000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01889-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":549,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01889-x","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Alberto Raggi: Associate Editor of the Journal of Headache and Pain, Head of Public Health Section of SN Comprehensive Clinical Medicine. Matilde Leonardi: Associate Editor of the Journal of Headache and Pain. Valeria Caponnetto, Personal fees and honoraria from AbbVie and Teva. Gianluca Coppola: Associate Editor of the Journal of Headache and Pain. Adriana Della Pietra: Junior Editorial Board member of the Journal of Headache and Pain. David Garcia-Azorin: Junior Editorial Board member of the Journal of Headache and Pain, and Editorial Board member of Neurological Sciences; he has received personal compensation for consulting\/advising from the World Health Organization; non-profit board membership in the Spanish Society of Neurology, and the European Union of Medical Specialist section of Neurology (UEMS); Research funding from the Carlos III Health Research Institute; and the Regional Health Administration (Gerencia Regional de Salud SACYL) in Castilla y Leon, Spain; speaker\/travel grants\/clinical trials from Teva, Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, and Biohaven. Alejandro Labastida-Ramirez: Junior Editorial Board member of the Journal of Headache and Pain. Dilara Onan: Junior Editorial Board member of The Journal of Headache and Pain. Lanfranco Pellesi: Junior Editorial Board member of the Journal of Headache and Pain; has been employed by Lundbeck in the past two years. Mario Peres: Associate Editor of the Journal of Headache and Pain. Igor Petru\u0161i\u0107: Junior Editorial Board member of the Journal of Headache and Pain. Bianca Raffaelli: Junior Editorial Board member of the Journal of Headache and Pain, Member of the Editorial Board of Frontiers in Neurology and BMC Neurology; Personal fees and honoraria from AbbVie, Eli Lilly, Lundbeck, Novartis, Teva; Research grants from Lundbeck, Novartis, German Research Foundation, German Migraine and Headache Society. Eloisa Rubio-Beltran:  Junior Editorial Board member of the Journal of Headache and Pain; Review Editor for Frontiers in Neurology \u2013 Headache and Neurogenic Pain. Andreas Straube: Associate Editor of the Journal of Headache and Pain. Sebastian Straube: grants from the Workers\u2019 Compensation Board of Alberta, The Government of Alberta, and the Alberta Medical Association; honoraria from the Occupational Medicine Specialist of Canada, the M.S.I. Foundation, and the Canadian Centre of Recovery Excellence. Tsubasa Takizawa: consultant\/advisor and\/or serves on an advisory board for Eli Lilly, Otsuka, Amgen, Pfizer, and Teijin; he has received speaker honoraria from Eli Lilly, Daiichi Sankyo, Otsuka, Amgen, Kowa, Kyowa Kirin, Eisai, UCB Japan, Takeda, and Santen Pharmaceutical and grant\/funding from Eli Lilly, Pfizer and Tsumura outside the submitted work. Claudio Tana: Junior Editorial Board member of the Journal of Headache and Pain. Doga Vuralli: Junior Editorial Board member of the Journal of Headache and Pain. Marta Waliszewska-Pros\u00f3\u0142: Junior Editorial Board member of the Journal of Headache and Pain. Wei Wang: Junior Editorial Board member of the Journal of Headache and Pain, Section Editor of SN Comprehensive Clinical Medicine. Yonggang Wang: Associate Editor of the Journal of Headache and Pain and Chair of Chinese headache society of CSA. William Wells-Gatnik: Junior Editorial Board member of the Journal of Headache and Pain. Tissa Wijeratne: Associate Editor of the Journal of Headache and Pain. Paolo Martelletti: Editor-in-Chief of the Journal of Headache and Pain and of SN Comprehensive Clinical Medicine; EU Expert, European Medicines Agency. Marco Arruda, Matteo Castaldo, Xiangning Fan, Parisa Gazerani, Lou Grangeon, Licia Grazzi, Fu-Jung Hsiao, Keiko Ihara, Kristin Sophie Lange, Marco Lisicki, Alessia Marcassoli, Danilo Antonio Montisano, Agnese Onofri, Michela Tinelli, Massimiliano Valeriani, Simone Vigneri, and Tissa Wijeratne report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}